CAMK4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14745 | S291 | Sugiyama | NHERF1 NHERF SLC9A3R1 | EALAEAALEsPRPALVRsAssDtsEELNsQDsPPKQDSTAP |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60220 | S96 | Sugiyama | TIMM8A DDP DDP1 TIM8A | FILNRLEQTQKSKPVFSEsLsD___________________ |
| O60292 | T175 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | WPRsPGRAFLPLRHRsssEItLSECDAEDAGEPRGARHtGA |
| O60343 | S485 | Sugiyama | TBC1D4 AS160 KIAA0603 | CERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPV |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O94776 | T621 | Sugiyama | MTA2 MTA1L1 PID | APNPVVFVATKDTRALRKALtHLEMRRAARRPNLPLKVKPT |
| O95197 | S316 | Sugiyama | RTN3 ASYIP NSPL2 | PLRNKEAGRYPMSALLSRQFsHtNAALEEVSRCVNDMHNFT |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95835 | S464 | Sugiyama | LATS1 WARTS | SPSSGHEIPTWQPNIPVRsNsFNNPLGNRASHSANSQPSAT |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04632 | Y87 | Sugiyama | CAPNS1 CAPN4 CAPNS | sAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLFAQ |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14866 | S544 | SIGNOR|EPSD|PSP | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16220 | S119 | SIGNOR|PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16949 | S16 | SIGNOR|EPSD|PSP | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18825 | S358 | Sugiyama | ADRA2C ADRA2L2 ADRA2RL2 | sPGPGGRLSRASSRsVEFFLsRRRRARSSVCRRKVAQAREK |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S2129 | Sugiyama | APC DP2.5 | NSIVSSLHQAAAAACLsRQAssDSDSILSLKsGIsLGsPFH |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29475 | S852 | SIGNOR|iPTMNet | NOS1 | EMRHPNSVQEERKSYKVRFNsVSSYSDsQKSSGDGPDLRDN |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | T150 | Sugiyama | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P50991 | S444 | Sugiyama | CCT4 CCTD SRB | GGGAPEIELALRLTEYSRTLsGMEsyCVRAFADAMEVIPST |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P56524 | S246 | GPS6|EPSD | HDAC4 KIAA0288 | NHPVLGMYDAKDDFPLRKTAsEPNLKLRSRLKQKVAERRss |
| P56524 | S467 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | HDAC4 KIAA0288 | DRVSPSIHKLRQHRPLGRtQsAPLPQNAQALQHLVIQQQHQ |
| P56524 | S632 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | HDAC4 KIAA0288 | MEAAGIPVSFGGHRPLsRAQssPAsAtFPVSVQEPPTKPRF |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62714 | S43 | Sugiyama | PPP2CB | LNENQVRTLCEKAKEILTKEsNVQEVRCPVTVCGDVHGQFH |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P67775 | S43 | Sugiyama | PPP2CA | LSESQVKSLCEKAKEILTKEsNVQEVRCPVTVCGDVHGQFH |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q04206 | S536 | EPSD|PSP | RELA NFKB3 | APLGAPGLPNGLLsGDEDFSsIADMDFsALLSQISS_____ |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09472 | S24 | GPS6|ELM|EPSD | EP300 P300 | NVVEPGPPsAKRPKLsSPALsASASDGTDFGSLFDLEHDLP |
| Q12965 | T939 | Sugiyama | MYO1E MYO1C | SIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPP |
| Q13439 | S41 | Sugiyama | GOLGA4 | APAQAssNsstPtRMRsRtssFtEQLDEGtPNRESGDTQSF |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16566 | S12 | GPS6|EPSD | CAMK4 CAMK CAMK-GR CAMKIV | _________MLKVTVPSCSAssCSSVTASAAPGTASLVPDY |
| Q16566 | S13 | GPS6|EPSD | CAMK4 CAMK CAMK-GR CAMKIV | ________MLKVTVPSCSAssCSSVTASAAPGTASLVPDYW |
| Q16566 | S336 | GPS6|EPSD | CAMK4 CAMK CAMK-GR CAMKIV | KLQEFNARRKLKAAVKAVVAsSRLGsAsssHGsIQEsHKAs |
| Q16566 | S341 | iPTMNet | CAMK4 CAMK CAMK-GR CAMKIV | NARRKLKAAVKAVVAsSRLGsAsssHGsIQEsHKAsRDPsP |
| Q16566 | S356 | Sugiyama | CAMK4 CAMK CAMK-GR CAMKIV | sSRLGsAsssHGsIQEsHKAsRDPsPIQDGNEDMKAIPEGE |
| Q16566 | S360 | iPTMNet|Sugiyama | CAMK4 CAMK CAMK-GR CAMKIV | GsAsssHGsIQEsHKAsRDPsPIQDGNEDMKAIPEGEKIQG |
| Q16566 | S58 | Sugiyama | CAMK4 CAMK CAMK-GR CAMKIV | NRDALSDFFEVESELGRGAtsIVYRCKQKGTQKPYALKVLK |
| Q16566 | T312 | Sugiyama | CAMK4 CAMK CAMK-GR CAMKIV | FQALQHPWVTGKAANFVHMDtAQKKLQEFNARRKLKAAVKA |
| Q16566 | T57 | Sugiyama | CAMK4 CAMK CAMK-GR CAMKIV | SNRDALSDFFEVESELGRGAtsIVYRCKQKGTQKPYALKVL |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5UIP0 | S1688 | Sugiyama | RIF1 | PVPESNLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssL |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z5L9 | S15 | Sugiyama | IRF2BP2 | ______MAAAVAVAAASRRQsCyLCDLPRMPWAMIWDFTEP |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8ND56 | S368 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EGNADEEDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEE |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q92793 | S302 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CREBBP CBP | QAGGQPMGATGVNPQLASKQsMVNSLPTFPTDIKNTSVTNV |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q99575 | S816 | Sugiyama | POP1 KIAA0061 | VAATGSHLCVLRSRKLLKQLsAWCGPSSEDSRGGRRAPGRG |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q99623 | S91 | SIGNOR|EPSD|PSP | PHB2 BAP REA | RIPWFQYPIIYDIRARPRKIssPTGSKDLQMVNISLRVLSR |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9H6S3 | S693 | Sugiyama | EPS8L2 EPS8R2 PP13181 | EGVRVySQLTMQKAFLEKQQsGSELEELMNKFHSMNQRRGE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NYF8 | S319 | Sugiyama | BCLAF1 BTF KIAA0164 | RsPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKR |
| Q9UHX1 | S461 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | sIsGssARHMVMQKLLRKQEsTVMVLRNMVDPKDIDDDLEG |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UNW9 | S194 | SIGNOR|PSP | NOVA2 ANOVA NOVA3 | NLQERVVTVSGEPEQVHKAVsAIVQKVQEDPQSSSCLNISY |
| Q9UNW9 | S25 | SIGNOR|PSP | NOVA2 ANOVA NOVA3 | APDSRKRPLETPPEVVCTKRsNtGEEGEYFLKVLIPSYAAG |
| Q9UNW9 | T27 | SIGNOR|PSP | NOVA2 ANOVA NOVA3 | DSRKRPLETPPEVVCTKRsNtGEEGEYFLKVLIPSYAAGSI |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQL6 | S259 | GPS6|SIGNOR|ELM|EPSD|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | GPS6|SIGNOR|ELM|EPSD|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y6J0 | S2126 | GPS6 | CABIN1 KIAA0330 | SGSAQPPEGHPGKPEPSRAKsRPLPNMPKLVIPSAATKFPP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 6.522843e-10 | 9.186 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.158209e-09 | 8.145 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.152901e-08 | 7.501 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.166476e-08 | 7.038 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.049175e-07 | 6.516 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.618537e-07 | 6.335 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.282503e-07 | 6.277 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.580708e-07 | 6.253 | 1 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.048567e-07 | 6.152 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.434443e-07 | 6.074 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.104246e-07 | 6.041 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.126335e-06 | 5.948 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.665037e-06 | 5.436 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.915019e-06 | 5.308 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.250808e-06 | 5.280 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.595321e-06 | 5.252 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.595321e-06 | 5.252 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.955068e-06 | 5.225 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.691958e-06 | 5.174 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.656726e-06 | 5.063 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.109299e-05 | 4.955 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.321924e-05 | 4.879 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.387654e-05 | 4.858 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.675827e-05 | 4.776 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.273295e-05 | 4.643 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.273295e-05 | 4.643 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.217410e-05 | 4.654 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.326423e-05 | 4.633 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.419507e-05 | 4.616 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.323903e-05 | 4.478 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.218716e-05 | 4.375 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.259735e-05 | 4.371 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.259735e-05 | 4.371 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.192755e-05 | 4.378 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.192755e-05 | 4.378 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.218716e-05 | 4.375 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.160511e-05 | 4.381 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.935121e-05 | 4.307 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.334486e-05 | 4.273 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.624588e-05 | 4.250 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.679772e-05 | 4.246 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.960464e-05 | 4.225 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.530872e-05 | 4.185 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.379995e-05 | 4.132 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.503641e-05 | 4.125 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.890541e-05 | 4.103 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.890541e-05 | 4.103 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.675714e-05 | 4.062 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.675714e-05 | 4.062 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.675714e-05 | 4.062 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.675714e-05 | 4.062 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.151250e-05 | 4.039 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.113247e-04 | 3.953 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.316088e-04 | 3.881 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.428700e-04 | 3.845 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.357826e-04 | 3.867 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.419022e-04 | 3.848 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.488470e-04 | 3.827 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.577381e-04 | 3.802 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.643527e-04 | 3.784 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.791026e-04 | 3.747 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.799572e-04 | 3.745 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.869073e-04 | 3.728 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.997502e-04 | 3.700 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.502893e-04 | 3.602 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.665148e-04 | 3.574 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.665148e-04 | 3.574 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.101101e-04 | 3.508 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.264096e-04 | 3.486 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.165191e-04 | 3.500 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.285010e-04 | 3.483 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.454137e-04 | 3.462 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.392952e-04 | 3.469 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.357296e-04 | 3.474 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.628325e-04 | 3.440 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.628325e-04 | 3.440 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.531575e-04 | 3.344 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.654705e-04 | 3.332 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.764864e-04 | 3.322 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.963520e-04 | 3.304 | 1 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.106395e-04 | 3.292 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.832227e-04 | 3.234 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.004459e-04 | 3.222 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.373661e-04 | 3.196 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.284633e-04 | 3.202 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.458074e-04 | 3.190 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.615102e-04 | 3.179 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.866399e-04 | 3.104 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.096853e-04 | 3.092 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.363286e-04 | 3.078 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.976379e-04 | 3.047 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.142352e-04 | 3.039 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 9.329725e-04 | 3.030 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 9.347513e-04 | 3.029 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.101356e-03 | 2.958 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.111751e-03 | 2.954 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.111751e-03 | 2.954 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.111225e-03 | 2.954 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.271621e-03 | 2.896 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.258889e-03 | 2.900 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.249086e-03 | 2.903 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.283815e-03 | 2.891 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.224137e-03 | 2.912 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.285212e-03 | 2.891 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.458505e-03 | 2.836 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.566796e-03 | 2.805 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.690440e-03 | 2.772 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.690440e-03 | 2.772 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.524084e-03 | 2.817 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.523412e-03 | 2.817 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.630612e-03 | 2.788 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.698659e-03 | 2.770 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.741894e-03 | 2.759 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.756040e-03 | 2.755 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.987562e-03 | 2.702 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.029070e-03 | 2.693 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.381091e-03 | 2.623 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.381091e-03 | 2.623 | 1 | 1 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.381091e-03 | 2.623 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.433740e-03 | 2.614 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.475140e-03 | 2.606 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.826488e-03 | 2.549 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.971844e-03 | 2.527 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.992302e-03 | 2.524 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 2.992302e-03 | 2.524 | 1 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.049468e-03 | 2.516 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.280905e-03 | 2.484 | 1 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.651777e-03 | 2.437 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.846827e-03 | 2.415 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.940883e-03 | 2.404 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.725369e-03 | 2.326 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.673240e-03 | 2.330 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.598964e-03 | 2.337 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.409767e-03 | 2.356 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.725369e-03 | 2.326 | 1 | 1 |
| Reproduction | R-HSA-1474165 | 4.402986e-03 | 2.356 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.887728e-03 | 2.311 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.124867e-03 | 2.290 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.223662e-03 | 2.282 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.274189e-03 | 2.278 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.285656e-03 | 2.277 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.325865e-03 | 2.274 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.401874e-03 | 2.267 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.550611e-03 | 2.256 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.433042e-03 | 2.192 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.434302e-03 | 2.191 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.434302e-03 | 2.191 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.756106e-03 | 2.170 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.882800e-03 | 2.162 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.228061e-03 | 2.141 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.091646e-03 | 2.149 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.568519e-03 | 2.121 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.914361e-03 | 2.102 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.955291e-03 | 2.099 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.469563e-03 | 2.072 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.534437e-03 | 2.069 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.687447e-03 | 2.061 | 1 | 1 |
| Programmed Cell Death | R-HSA-5357801 | 8.937894e-03 | 2.049 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.941235e-03 | 2.049 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.230086e-03 | 2.035 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.479212e-03 | 2.023 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.816293e-03 | 2.008 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 9.855378e-03 | 2.006 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 9.855378e-03 | 2.006 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 9.855378e-03 | 2.006 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.050302e-02 | 1.979 | 1 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.156198e-02 | 1.937 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.156198e-02 | 1.937 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.168457e-02 | 1.932 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.078753e-02 | 1.967 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.198190e-02 | 1.921 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.199737e-02 | 1.921 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.201613e-02 | 1.920 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.226176e-02 | 1.911 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.243938e-02 | 1.905 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.244174e-02 | 1.905 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.257737e-02 | 1.900 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.257737e-02 | 1.900 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.257737e-02 | 1.900 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.353935e-02 | 1.868 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.359988e-02 | 1.866 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.426060e-02 | 1.846 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.471474e-02 | 1.832 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.473169e-02 | 1.832 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.494964e-02 | 1.825 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.701000e-02 | 1.769 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.744224e-02 | 1.758 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.732862e-02 | 1.761 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.558064e-02 | 1.807 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.651390e-02 | 1.782 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.617448e-02 | 1.791 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.744416e-02 | 1.758 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.772379e-02 | 1.751 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.803023e-02 | 1.744 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.848015e-02 | 1.733 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.870119e-02 | 1.728 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.870119e-02 | 1.728 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.870119e-02 | 1.728 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.870119e-02 | 1.728 | 1 | 1 |
| Integrin signaling | R-HSA-354192 | 2.060666e-02 | 1.686 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.063781e-02 | 1.685 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.092826e-02 | 1.679 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.092826e-02 | 1.679 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.173517e-02 | 1.663 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.269541e-02 | 1.644 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.295204e-02 | 1.639 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.353321e-02 | 1.628 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.357434e-02 | 1.628 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.373385e-02 | 1.625 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.417468e-02 | 1.617 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.422716e-02 | 1.616 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.438321e-02 | 1.613 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.456843e-02 | 1.610 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.522710e-02 | 1.598 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.591383e-02 | 1.586 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.832732e-02 | 1.548 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.838596e-02 | 1.547 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.992774e-02 | 1.524 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.035682e-02 | 1.518 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.112805e-02 | 1.507 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.118455e-02 | 1.506 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.119541e-02 | 1.506 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.119541e-02 | 1.506 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.119541e-02 | 1.506 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.119541e-02 | 1.506 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.119541e-02 | 1.506 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.137810e-02 | 1.503 | 1 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.213059e-02 | 1.493 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.297214e-02 | 1.482 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.376766e-02 | 1.471 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.392206e-02 | 1.470 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.404633e-02 | 1.468 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.424607e-02 | 1.465 | 1 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.454506e-02 | 1.462 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.466884e-02 | 1.460 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.535567e-02 | 1.452 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.535567e-02 | 1.452 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.569732e-02 | 1.447 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.755096e-02 | 1.425 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.875073e-02 | 1.412 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.057989e-02 | 1.392 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.057989e-02 | 1.392 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.871059e-02 | 1.312 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.525496e-02 | 1.344 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.297615e-02 | 1.367 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.704336e-02 | 1.328 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.954621e-02 | 1.305 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.492592e-02 | 1.348 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.954621e-02 | 1.305 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.572430e-02 | 1.340 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.934819e-02 | 1.307 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.871059e-02 | 1.312 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.000002e-02 | 1.301 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.000002e-02 | 1.301 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.000002e-02 | 1.301 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.000002e-02 | 1.301 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.462043e-02 | 1.263 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.492824e-02 | 1.260 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.539125e-02 | 1.257 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.731374e-02 | 1.242 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.758396e-02 | 1.240 | 1 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.893760e-02 | 1.230 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.935833e-02 | 1.227 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.249549e-02 | 1.204 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.281793e-02 | 1.202 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.281793e-02 | 1.202 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.281793e-02 | 1.202 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.281793e-02 | 1.202 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.289352e-02 | 1.201 | 1 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.314834e-02 | 1.200 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.425120e-02 | 1.192 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.425120e-02 | 1.192 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 6.425120e-02 | 1.192 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.475943e-02 | 1.189 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.614827e-02 | 1.179 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.614827e-02 | 1.179 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.633679e-02 | 1.178 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.935330e-02 | 1.159 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.248557e-02 | 1.140 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 7.248557e-02 | 1.140 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 7.248557e-02 | 1.140 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.248557e-02 | 1.140 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.437745e-02 | 1.074 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.099302e-02 | 1.149 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.358237e-02 | 1.133 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.588457e-02 | 1.120 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.376353e-02 | 1.077 | 1 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.166697e-02 | 1.145 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.109938e-02 | 1.091 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.109938e-02 | 1.091 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.809554e-02 | 1.107 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.809554e-02 | 1.107 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.809554e-02 | 1.107 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.248557e-02 | 1.140 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.702247e-02 | 1.113 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.992073e-02 | 1.097 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.437745e-02 | 1.074 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.437745e-02 | 1.074 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.531485e-02 | 1.069 | 1 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.618814e-02 | 1.065 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.642881e-02 | 1.063 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.642881e-02 | 1.063 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.642881e-02 | 1.063 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.642881e-02 | 1.063 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.684161e-02 | 1.061 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.724439e-02 | 1.059 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.157143e-02 | 1.038 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.157143e-02 | 1.038 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.157143e-02 | 1.038 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.228312e-02 | 1.035 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.308863e-02 | 1.031 | 1 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.439471e-02 | 1.025 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.591458e-02 | 1.018 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 9.822522e-02 | 1.008 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 9.822522e-02 | 1.008 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 9.822522e-02 | 1.008 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 9.822522e-02 | 1.008 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 9.822522e-02 | 1.008 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 9.822522e-02 | 1.008 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.894682e-02 | 1.005 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.894682e-02 | 1.005 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.894682e-02 | 1.005 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.894682e-02 | 1.005 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.894682e-02 | 1.005 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.894682e-02 | 1.005 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.046739e-01 | 0.980 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.046739e-01 | 0.980 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.046739e-01 | 0.980 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.049434e-01 | 0.979 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.049434e-01 | 0.979 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.034675e-01 | 0.985 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.034675e-01 | 0.985 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.220313e-01 | 0.914 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.220313e-01 | 0.914 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.146227e-01 | 0.941 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.265687e-01 | 0.898 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.236211e-01 | 0.908 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.245298e-01 | 0.905 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.220313e-01 | 0.914 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.067481e-01 | 0.972 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.146227e-01 | 0.941 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.163994e-01 | 0.934 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.049434e-01 | 0.979 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.049434e-01 | 0.979 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.144050e-01 | 0.942 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.026257e-01 | 0.989 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.158832e-01 | 0.936 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.265687e-01 | 0.898 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.067529e-01 | 0.972 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.022063e-01 | 0.991 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.022257e-01 | 0.990 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.062141e-01 | 0.974 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.114096e-01 | 0.953 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.220313e-01 | 0.914 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.115658e-01 | 0.952 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.115658e-01 | 0.952 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.268957e-01 | 0.897 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.270670e-01 | 0.896 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.270670e-01 | 0.896 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.270670e-01 | 0.896 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.270670e-01 | 0.896 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.275433e-01 | 0.894 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.275433e-01 | 0.894 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.277567e-01 | 0.894 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.277567e-01 | 0.894 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.277567e-01 | 0.894 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.277567e-01 | 0.894 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.314659e-01 | 0.881 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.314659e-01 | 0.881 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.314659e-01 | 0.881 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.314659e-01 | 0.881 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.314659e-01 | 0.881 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.314659e-01 | 0.881 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.334271e-01 | 0.875 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.339347e-01 | 0.873 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.345589e-01 | 0.871 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.374128e-01 | 0.862 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.398710e-01 | 0.854 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.398710e-01 | 0.854 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.406954e-01 | 0.852 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.414819e-01 | 0.849 | 1 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.420213e-01 | 0.848 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.420213e-01 | 0.848 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.420213e-01 | 0.848 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.420213e-01 | 0.848 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.438296e-01 | 0.842 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.500432e-01 | 0.824 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.500432e-01 | 0.824 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.500432e-01 | 0.824 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.584967e-01 | 0.800 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.584967e-01 | 0.800 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.584967e-01 | 0.800 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.919918e-01 | 0.717 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.919918e-01 | 0.717 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.519721e-01 | 0.818 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.519721e-01 | 0.818 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.519721e-01 | 0.818 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.780029e-01 | 0.750 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.780029e-01 | 0.750 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.780029e-01 | 0.750 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.780029e-01 | 0.750 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.780029e-01 | 0.750 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.780029e-01 | 0.750 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.780029e-01 | 0.750 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.633217e-01 | 0.787 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.633217e-01 | 0.787 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.858029e-01 | 0.731 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.883136e-01 | 0.725 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.701038e-01 | 0.769 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.701038e-01 | 0.769 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.541574e-01 | 0.812 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.880677e-01 | 0.726 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.880677e-01 | 0.726 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.862632e-01 | 0.730 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.835356e-01 | 0.736 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.573478e-01 | 0.803 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.762069e-01 | 0.754 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.571978e-01 | 0.804 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.852146e-01 | 0.732 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.780029e-01 | 0.750 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.633217e-01 | 0.787 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.462309e-01 | 0.835 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.883136e-01 | 0.725 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.541574e-01 | 0.812 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.718962e-01 | 0.765 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.684289e-01 | 0.774 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.584967e-01 | 0.800 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.919918e-01 | 0.717 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.519721e-01 | 0.818 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.494132e-01 | 0.826 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.698654e-01 | 0.770 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.649259e-01 | 0.783 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.883136e-01 | 0.725 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.662329e-01 | 0.779 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.504112e-01 | 0.823 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.462309e-01 | 0.835 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.688889e-01 | 0.772 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.921483e-01 | 0.716 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.880677e-01 | 0.726 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.545967e-01 | 0.811 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.493228e-01 | 0.826 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.919918e-01 | 0.717 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.448480e-01 | 0.839 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.391980e-01 | 0.621 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.391980e-01 | 0.621 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.391980e-01 | 0.621 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.391980e-01 | 0.621 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.984368e-01 | 0.702 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.984368e-01 | 0.702 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.984368e-01 | 0.702 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.984368e-01 | 0.702 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.984368e-01 | 0.702 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.984368e-01 | 0.702 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.984368e-01 | 0.702 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.364068e-01 | 0.473 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.364068e-01 | 0.473 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.364068e-01 | 0.473 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.364068e-01 | 0.473 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.364068e-01 | 0.473 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.364068e-01 | 0.473 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.364068e-01 | 0.473 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.364068e-01 | 0.473 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.364068e-01 | 0.473 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 3.364068e-01 | 0.473 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.364068e-01 | 0.473 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.364068e-01 | 0.473 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.364068e-01 | 0.473 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.364068e-01 | 0.473 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.364068e-01 | 0.473 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.364068e-01 | 0.473 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.364068e-01 | 0.473 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.483423e-01 | 0.605 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.483423e-01 | 0.605 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.483423e-01 | 0.605 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.483423e-01 | 0.605 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.483423e-01 | 0.605 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.270432e-01 | 0.644 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.270432e-01 | 0.644 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.270432e-01 | 0.644 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.270432e-01 | 0.644 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.985842e-01 | 0.525 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.985842e-01 | 0.525 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.985842e-01 | 0.525 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.985842e-01 | 0.525 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.212000e-01 | 0.376 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.212000e-01 | 0.376 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.212000e-01 | 0.376 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.212000e-01 | 0.376 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.212000e-01 | 0.376 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.212000e-01 | 0.376 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.212000e-01 | 0.376 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.212000e-01 | 0.376 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.212000e-01 | 0.376 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.212000e-01 | 0.376 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.212000e-01 | 0.376 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.212000e-01 | 0.376 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.212000e-01 | 0.376 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.212000e-01 | 0.376 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.053957e-01 | 0.687 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.053957e-01 | 0.687 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.631703e-01 | 0.580 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.482622e-01 | 0.458 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.482622e-01 | 0.458 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.482622e-01 | 0.458 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.999306e-01 | 0.523 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.999306e-01 | 0.523 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.999306e-01 | 0.523 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.999306e-01 | 0.523 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.999306e-01 | 0.523 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.999306e-01 | 0.523 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.999306e-01 | 0.523 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.632874e-01 | 0.580 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.337443e-01 | 0.631 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.337443e-01 | 0.631 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.090923e-01 | 0.680 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.067636e-01 | 0.685 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.067636e-01 | 0.685 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.589097e-01 | 0.587 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.589097e-01 | 0.587 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.933037e-01 | 0.533 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.369253e-01 | 0.472 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.369253e-01 | 0.472 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.369253e-01 | 0.472 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.369253e-01 | 0.472 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.967008e-01 | 0.402 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.967008e-01 | 0.402 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.967008e-01 | 0.402 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.967008e-01 | 0.402 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.967008e-01 | 0.402 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.967008e-01 | 0.402 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.951627e-01 | 0.305 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.951627e-01 | 0.305 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.951627e-01 | 0.305 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.951627e-01 | 0.305 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.951627e-01 | 0.305 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.951627e-01 | 0.305 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.951627e-01 | 0.305 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 4.951627e-01 | 0.305 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.951627e-01 | 0.305 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.951627e-01 | 0.305 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.033043e-01 | 0.692 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.033043e-01 | 0.692 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.528262e-01 | 0.597 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.528262e-01 | 0.597 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.528262e-01 | 0.597 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.528262e-01 | 0.597 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.846721e-01 | 0.546 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.846721e-01 | 0.546 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.992180e-01 | 0.701 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.992180e-01 | 0.701 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.992180e-01 | 0.701 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.237264e-01 | 0.490 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.755783e-01 | 0.560 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.738023e-01 | 0.427 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.738023e-01 | 0.427 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.738023e-01 | 0.427 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.987828e-01 | 0.525 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.434058e-01 | 0.353 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.434058e-01 | 0.353 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.434058e-01 | 0.353 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.434058e-01 | 0.353 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.434058e-01 | 0.353 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.223365e-01 | 0.492 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.223365e-01 | 0.492 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.102560e-01 | 0.387 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.849498e-01 | 0.415 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.248957e-01 | 0.648 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.640839e-01 | 0.439 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.461384e-01 | 0.461 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.461384e-01 | 0.461 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.554559e-01 | 0.593 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.700899e-01 | 0.432 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.700899e-01 | 0.432 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.908032e-01 | 0.408 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.908032e-01 | 0.408 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.460267e-01 | 0.351 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.460267e-01 | 0.351 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.880294e-01 | 0.312 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.880294e-01 | 0.312 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.880294e-01 | 0.312 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.596778e-01 | 0.252 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.596778e-01 | 0.252 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.596778e-01 | 0.252 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.596778e-01 | 0.252 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.258909e-01 | 0.487 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.739790e-01 | 0.427 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.038802e-01 | 0.517 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.174355e-01 | 0.379 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.765490e-01 | 0.424 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.912793e-01 | 0.536 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.912793e-01 | 0.536 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.808979e-01 | 0.318 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.808979e-01 | 0.318 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.808979e-01 | 0.318 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.808979e-01 | 0.318 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.808979e-01 | 0.318 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.286347e-01 | 0.641 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.750153e-01 | 0.323 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.750153e-01 | 0.323 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.303412e-01 | 0.275 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.303412e-01 | 0.275 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.303412e-01 | 0.275 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.303412e-01 | 0.275 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.146935e-01 | 0.288 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.893946e-01 | 0.410 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.039687e-01 | 0.298 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.957186e-01 | 0.305 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.734873e-01 | 0.325 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.654824e-01 | 0.332 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.654824e-01 | 0.332 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.069004e-01 | 0.391 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.044726e-01 | 0.297 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.321926e-01 | 0.274 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.472742e-01 | 0.262 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.472742e-01 | 0.262 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.472742e-01 | 0.262 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.472742e-01 | 0.262 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.472742e-01 | 0.262 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.702033e-01 | 0.244 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.702033e-01 | 0.244 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 5.702033e-01 | 0.244 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.813491e-01 | 0.318 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.108705e-01 | 0.292 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.342151e-01 | 0.362 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.456447e-01 | 0.263 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.150146e-01 | 0.288 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.292561e-01 | 0.276 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.371227e-01 | 0.270 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.276637e-01 | 0.278 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.276637e-01 | 0.278 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.785341e-01 | 0.238 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.562448e-01 | 0.255 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.074352e-01 | 0.390 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.484518e-01 | 0.261 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.209607e-01 | 0.283 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.456447e-01 | 0.263 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.655351e-01 | 0.437 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.282820e-01 | 0.484 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.785341e-01 | 0.238 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.785341e-01 | 0.238 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.849498e-01 | 0.415 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.850169e-01 | 0.545 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.988933e-01 | 0.524 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.337443e-01 | 0.631 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.992180e-01 | 0.701 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.745244e-01 | 0.561 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.093257e-01 | 0.679 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.567943e-01 | 0.254 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.698409e-01 | 0.569 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.739790e-01 | 0.427 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.282820e-01 | 0.484 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.543413e-01 | 0.451 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.543413e-01 | 0.451 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.144093e-01 | 0.383 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.223365e-01 | 0.492 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.638295e-01 | 0.249 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.376783e-01 | 0.359 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.176926e-01 | 0.286 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.176926e-01 | 0.286 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.793216e-01 | 0.421 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.209383e-01 | 0.656 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.987828e-01 | 0.525 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.460267e-01 | 0.351 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.142901e-01 | 0.383 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.831538e-01 | 0.316 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.802664e-01 | 0.420 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.053957e-01 | 0.687 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.087308e-01 | 0.510 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.321709e-01 | 0.274 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.522462e-01 | 0.258 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.004411e-01 | 0.522 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.038802e-01 | 0.517 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.270432e-01 | 0.644 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.631703e-01 | 0.580 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.874555e-01 | 0.541 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.102560e-01 | 0.387 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.849498e-01 | 0.415 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.484277e-01 | 0.348 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.473935e-01 | 0.262 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.965655e-01 | 0.402 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.965655e-01 | 0.402 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.378800e-01 | 0.624 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.934336e-01 | 0.405 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.180675e-01 | 0.379 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.174355e-01 | 0.379 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.984368e-01 | 0.702 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.985842e-01 | 0.525 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.543413e-01 | 0.451 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.434058e-01 | 0.353 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.808979e-01 | 0.318 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.303412e-01 | 0.275 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.406114e-01 | 0.468 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.146935e-01 | 0.288 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.146935e-01 | 0.288 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.472742e-01 | 0.262 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.849498e-01 | 0.415 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.984368e-01 | 0.702 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.270432e-01 | 0.644 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.067636e-01 | 0.685 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.369253e-01 | 0.472 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.967008e-01 | 0.402 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.738023e-01 | 0.427 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.738023e-01 | 0.427 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.434058e-01 | 0.353 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.102560e-01 | 0.387 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.808979e-01 | 0.318 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.374003e-01 | 0.472 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.461614e-01 | 0.263 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.660470e-01 | 0.247 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.427870e-01 | 0.615 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.697061e-01 | 0.244 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.438666e-01 | 0.353 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.613375e-01 | 0.336 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.738023e-01 | 0.427 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.562369e-01 | 0.448 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.108705e-01 | 0.292 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.739790e-01 | 0.427 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.664427e-01 | 0.247 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.664427e-01 | 0.247 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.489142e-01 | 0.260 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.750153e-01 | 0.323 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.934336e-01 | 0.405 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.322998e-01 | 0.634 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.100241e-01 | 0.292 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.180675e-01 | 0.379 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.512344e-01 | 0.454 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 1.984368e-01 | 0.702 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.270432e-01 | 0.644 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.339053e-01 | 0.631 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.482622e-01 | 0.458 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.369253e-01 | 0.472 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.967008e-01 | 0.402 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.434058e-01 | 0.353 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.434058e-01 | 0.353 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.434058e-01 | 0.353 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.700899e-01 | 0.432 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.419182e-01 | 0.355 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.419182e-01 | 0.355 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.783815e-01 | 0.422 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.702033e-01 | 0.244 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.785341e-01 | 0.238 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.579395e-01 | 0.339 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.282796e-01 | 0.368 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.830699e-01 | 0.548 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.258537e-01 | 0.646 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.069666e-01 | 0.684 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.556727e-01 | 0.592 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.087308e-01 | 0.510 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.456447e-01 | 0.263 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.830699e-01 | 0.548 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.171637e-01 | 0.499 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.461614e-01 | 0.263 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.265111e-01 | 0.645 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.647885e-01 | 0.438 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.472742e-01 | 0.262 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.949641e-01 | 0.403 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.171637e-01 | 0.499 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.092534e-01 | 0.388 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.287816e-01 | 0.368 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.467834e-01 | 0.350 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.984368e-01 | 0.702 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.631703e-01 | 0.580 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.631703e-01 | 0.580 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.632874e-01 | 0.580 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.849498e-01 | 0.415 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.954006e-01 | 0.530 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.808979e-01 | 0.318 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.419182e-01 | 0.355 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.386686e-01 | 0.358 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.403462e-01 | 0.619 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.874555e-01 | 0.541 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.780593e-01 | 0.321 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.161427e-01 | 0.665 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.111272e-01 | 0.675 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.294696e-01 | 0.639 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.325617e-01 | 0.274 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.467834e-01 | 0.350 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.482622e-01 | 0.458 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.463340e-01 | 0.608 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.799588e-01 | 0.420 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.303412e-01 | 0.275 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.472742e-01 | 0.262 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.422157e-01 | 0.466 | 1 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.700406e-01 | 0.569 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.739790e-01 | 0.427 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.160521e-01 | 0.500 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.115810e-01 | 0.386 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.664427e-01 | 0.247 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.090629e-01 | 0.510 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.802664e-01 | 0.420 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.292561e-01 | 0.276 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.698114e-01 | 0.328 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.209607e-01 | 0.283 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.579395e-01 | 0.339 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.579395e-01 | 0.339 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.579395e-01 | 0.339 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.119824e-01 | 0.291 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.592262e-01 | 0.445 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.984368e-01 | 0.702 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.984368e-01 | 0.702 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.483423e-01 | 0.605 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.985842e-01 | 0.525 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.212000e-01 | 0.376 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.093257e-01 | 0.679 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.369253e-01 | 0.472 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.369253e-01 | 0.472 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.951627e-01 | 0.305 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.434058e-01 | 0.353 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.434058e-01 | 0.353 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.434058e-01 | 0.353 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.434058e-01 | 0.353 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.849498e-01 | 0.415 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.511536e-01 | 0.600 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.460267e-01 | 0.351 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.880294e-01 | 0.312 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.596778e-01 | 0.252 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.596778e-01 | 0.252 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.596778e-01 | 0.252 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.596778e-01 | 0.252 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.596778e-01 | 0.252 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.592262e-01 | 0.445 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.699924e-01 | 0.328 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.146935e-01 | 0.288 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.524110e-01 | 0.344 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.472742e-01 | 0.262 | 1 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.702033e-01 | 0.244 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.567943e-01 | 0.254 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.679776e-01 | 0.246 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.799588e-01 | 0.420 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.799588e-01 | 0.420 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.755783e-01 | 0.560 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.700406e-01 | 0.569 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.360516e-01 | 0.474 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.146935e-01 | 0.288 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.098205e-01 | 0.678 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.549415e-01 | 0.594 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.880294e-01 | 0.312 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.654824e-01 | 0.332 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.472742e-01 | 0.262 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.214688e-01 | 0.375 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.970499e-01 | 0.401 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.592262e-01 | 0.445 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.483423e-01 | 0.605 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.270432e-01 | 0.644 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.102560e-01 | 0.387 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.460267e-01 | 0.351 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.454406e-01 | 0.351 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 5.303412e-01 | 0.275 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.321926e-01 | 0.274 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.262049e-01 | 0.279 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.041997e-01 | 0.690 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.794650e-01 | 0.554 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.108705e-01 | 0.292 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.987828e-01 | 0.525 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.093257e-01 | 0.679 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.808979e-01 | 0.318 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.384810e-01 | 0.470 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.126248e-01 | 0.672 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.738023e-01 | 0.427 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.970499e-01 | 0.401 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.010510e-01 | 0.521 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.640839e-01 | 0.439 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.785341e-01 | 0.238 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.745244e-01 | 0.561 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.985842e-01 | 0.525 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.212000e-01 | 0.376 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.631703e-01 | 0.580 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.999306e-01 | 0.523 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.434058e-01 | 0.353 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.434058e-01 | 0.353 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.493228e-01 | 0.603 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.640839e-01 | 0.439 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.030861e-01 | 0.518 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.880294e-01 | 0.312 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.596778e-01 | 0.252 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.146935e-01 | 0.288 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.702033e-01 | 0.244 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.403247e-01 | 0.468 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.456447e-01 | 0.263 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.039687e-01 | 0.298 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.254906e-01 | 0.279 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.456447e-01 | 0.263 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.750153e-01 | 0.323 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.962983e-01 | 0.528 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.419182e-01 | 0.355 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.784670e-01 | 0.238 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.074728e-01 | 0.512 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.808979e-01 | 0.318 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.785341e-01 | 0.238 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.119824e-01 | 0.291 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.483423e-01 | 0.605 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.985842e-01 | 0.525 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.967008e-01 | 0.402 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.967008e-01 | 0.402 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.967008e-01 | 0.402 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.434058e-01 | 0.353 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.596778e-01 | 0.252 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.596778e-01 | 0.252 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.039687e-01 | 0.298 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.438666e-01 | 0.353 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.339053e-01 | 0.631 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.880294e-01 | 0.312 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.543413e-01 | 0.451 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.985842e-01 | 0.525 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.808979e-01 | 0.318 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.652526e-01 | 0.248 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.655689e-01 | 0.332 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.252843e-01 | 0.371 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.150146e-01 | 0.288 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.646968e-01 | 0.577 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.460267e-01 | 0.351 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.303412e-01 | 0.275 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.403536e-01 | 0.356 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.828057e-01 | 0.234 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.861048e-01 | 0.232 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.861048e-01 | 0.232 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.861048e-01 | 0.232 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.862967e-01 | 0.232 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.862967e-01 | 0.232 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.863801e-01 | 0.232 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.930901e-01 | 0.227 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.934333e-01 | 0.227 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.982668e-01 | 0.223 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.995927e-01 | 0.222 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.000277e-01 | 0.222 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.000277e-01 | 0.222 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.000277e-01 | 0.222 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.006156e-01 | 0.221 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.056899e-01 | 0.218 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.075508e-01 | 0.216 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.075508e-01 | 0.216 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.075508e-01 | 0.216 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.075508e-01 | 0.216 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.075508e-01 | 0.216 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.075508e-01 | 0.216 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.075508e-01 | 0.216 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.075508e-01 | 0.216 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.075508e-01 | 0.216 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.083968e-01 | 0.216 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.083968e-01 | 0.216 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.083968e-01 | 0.216 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.083968e-01 | 0.216 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.116592e-01 | 0.213 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.116592e-01 | 0.213 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.116592e-01 | 0.213 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.116592e-01 | 0.213 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.157509e-01 | 0.211 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.157509e-01 | 0.211 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.159514e-01 | 0.210 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.159514e-01 | 0.210 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.159514e-01 | 0.210 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.159514e-01 | 0.210 | 1 | 1 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.159514e-01 | 0.210 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.159514e-01 | 0.210 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.159514e-01 | 0.210 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.159514e-01 | 0.210 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.159514e-01 | 0.210 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.159514e-01 | 0.210 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.159514e-01 | 0.210 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.201352e-01 | 0.208 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.201352e-01 | 0.208 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.201352e-01 | 0.208 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.300568e-01 | 0.201 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.331584e-01 | 0.198 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.333897e-01 | 0.198 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.340510e-01 | 0.198 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.362142e-01 | 0.196 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.362142e-01 | 0.196 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.363852e-01 | 0.196 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.368118e-01 | 0.196 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.368118e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.368118e-01 | 0.196 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.368118e-01 | 0.196 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.368118e-01 | 0.196 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.376516e-01 | 0.195 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.423753e-01 | 0.192 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.423753e-01 | 0.192 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.423753e-01 | 0.192 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.423753e-01 | 0.192 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.423753e-01 | 0.192 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.423753e-01 | 0.192 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.423753e-01 | 0.192 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.423753e-01 | 0.192 | 1 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.423753e-01 | 0.192 | 1 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.423753e-01 | 0.192 | 1 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.423753e-01 | 0.192 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.429819e-01 | 0.192 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.450490e-01 | 0.190 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.461676e-01 | 0.190 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.461676e-01 | 0.190 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.494919e-01 | 0.187 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.562865e-01 | 0.183 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.587632e-01 | 0.181 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.587632e-01 | 0.181 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.597373e-01 | 0.181 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.597373e-01 | 0.181 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.597373e-01 | 0.181 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.608346e-01 | 0.180 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.628458e-01 | 0.179 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.637512e-01 | 0.178 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.637512e-01 | 0.178 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.637512e-01 | 0.178 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.637512e-01 | 0.178 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.637512e-01 | 0.178 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.650361e-01 | 0.177 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.650361e-01 | 0.177 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.650361e-01 | 0.177 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.650361e-01 | 0.177 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.650361e-01 | 0.177 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.650361e-01 | 0.177 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.650361e-01 | 0.177 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.650361e-01 | 0.177 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.650361e-01 | 0.177 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.650361e-01 | 0.177 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.650361e-01 | 0.177 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.650361e-01 | 0.177 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.650361e-01 | 0.177 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.650361e-01 | 0.177 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.650361e-01 | 0.177 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.650361e-01 | 0.177 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.650361e-01 | 0.177 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.650361e-01 | 0.177 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.650361e-01 | 0.177 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.731716e-01 | 0.172 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.747117e-01 | 0.171 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.747117e-01 | 0.171 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.747117e-01 | 0.171 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.747117e-01 | 0.171 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.747117e-01 | 0.171 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.747117e-01 | 0.171 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.747117e-01 | 0.171 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.747117e-01 | 0.171 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.747117e-01 | 0.171 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.781345e-01 | 0.169 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.790645e-01 | 0.168 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.790645e-01 | 0.168 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.822079e-01 | 0.166 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.822079e-01 | 0.166 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.822079e-01 | 0.166 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.822150e-01 | 0.166 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.822150e-01 | 0.166 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.892064e-01 | 0.162 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.892064e-01 | 0.162 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.892064e-01 | 0.162 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.892064e-01 | 0.162 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.892064e-01 | 0.162 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.947581e-01 | 0.158 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.947581e-01 | 0.158 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.947581e-01 | 0.158 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.947581e-01 | 0.158 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.963089e-01 | 0.157 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.963089e-01 | 0.157 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.985410e-01 | 0.156 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.985410e-01 | 0.156 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.008790e-01 | 0.154 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.036153e-01 | 0.153 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.036153e-01 | 0.153 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.036153e-01 | 0.153 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.046269e-01 | 0.152 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.046269e-01 | 0.152 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.046269e-01 | 0.152 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.046269e-01 | 0.152 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.046269e-01 | 0.152 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.046269e-01 | 0.152 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.046269e-01 | 0.152 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.046269e-01 | 0.152 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.078498e-01 | 0.150 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.078498e-01 | 0.150 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.078498e-01 | 0.150 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.078498e-01 | 0.150 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.078498e-01 | 0.150 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.078498e-01 | 0.150 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.078498e-01 | 0.150 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.078498e-01 | 0.150 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.100091e-01 | 0.149 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.110254e-01 | 0.148 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.117376e-01 | 0.148 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.131849e-01 | 0.147 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.131849e-01 | 0.147 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.131849e-01 | 0.147 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.131849e-01 | 0.147 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.131849e-01 | 0.147 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.167369e-01 | 0.145 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.239585e-01 | 0.140 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.239585e-01 | 0.140 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.275981e-01 | 0.138 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.322117e-01 | 0.135 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.322117e-01 | 0.135 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.322117e-01 | 0.135 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.322117e-01 | 0.135 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.322117e-01 | 0.135 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.322117e-01 | 0.135 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.322117e-01 | 0.135 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.322117e-01 | 0.135 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.322117e-01 | 0.135 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.349935e-01 | 0.134 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.357079e-01 | 0.133 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.357079e-01 | 0.133 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.357079e-01 | 0.133 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.357079e-01 | 0.133 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.357079e-01 | 0.133 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.357079e-01 | 0.133 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.362051e-01 | 0.133 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.367389e-01 | 0.133 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.371703e-01 | 0.132 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.421072e-01 | 0.130 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.432441e-01 | 0.129 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.432441e-01 | 0.129 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.451934e-01 | 0.128 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.451934e-01 | 0.128 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.451934e-01 | 0.128 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.451934e-01 | 0.128 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.451934e-01 | 0.128 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.451934e-01 | 0.128 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.451934e-01 | 0.128 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.451934e-01 | 0.128 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.451934e-01 | 0.128 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.451934e-01 | 0.128 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.451934e-01 | 0.128 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.451934e-01 | 0.128 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.451934e-01 | 0.128 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.451934e-01 | 0.128 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.451934e-01 | 0.128 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.451934e-01 | 0.128 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.451934e-01 | 0.128 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.457281e-01 | 0.127 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.467033e-01 | 0.127 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.474721e-01 | 0.126 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.478734e-01 | 0.126 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.502215e-01 | 0.125 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.519702e-01 | 0.124 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.536577e-01 | 0.123 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.559876e-01 | 0.121 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.559876e-01 | 0.121 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.568077e-01 | 0.121 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.568077e-01 | 0.121 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.575729e-01 | 0.121 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.575729e-01 | 0.121 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.575729e-01 | 0.121 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.575729e-01 | 0.121 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.575729e-01 | 0.121 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.575729e-01 | 0.121 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.575729e-01 | 0.121 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.575729e-01 | 0.121 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.607712e-01 | 0.119 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.609450e-01 | 0.119 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.628171e-01 | 0.118 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.638658e-01 | 0.117 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.662213e-01 | 0.116 | 1 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 7.681223e-01 | 0.115 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.693593e-01 | 0.114 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.693593e-01 | 0.114 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.698019e-01 | 0.114 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.765253e-01 | 0.110 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.765253e-01 | 0.110 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.765253e-01 | 0.110 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.765253e-01 | 0.110 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.777656e-01 | 0.109 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.777656e-01 | 0.109 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.777656e-01 | 0.109 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.777656e-01 | 0.109 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.777656e-01 | 0.109 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.777656e-01 | 0.109 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.777656e-01 | 0.109 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.777656e-01 | 0.109 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.777656e-01 | 0.109 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.777656e-01 | 0.109 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.777656e-01 | 0.109 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.787032e-01 | 0.109 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.787032e-01 | 0.109 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.787669e-01 | 0.109 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.798609e-01 | 0.108 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.801813e-01 | 0.108 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.808281e-01 | 0.107 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.808281e-01 | 0.107 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.808281e-01 | 0.107 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.808281e-01 | 0.107 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.859765e-01 | 0.105 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.885483e-01 | 0.103 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.919827e-01 | 0.101 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.943139e-01 | 0.100 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.943202e-01 | 0.100 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.949088e-01 | 0.100 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.949088e-01 | 0.100 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.949088e-01 | 0.100 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.949088e-01 | 0.100 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.949208e-01 | 0.100 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.949208e-01 | 0.100 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.949208e-01 | 0.100 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.980022e-01 | 0.098 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.980022e-01 | 0.098 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.980022e-01 | 0.098 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.021013e-01 | 0.096 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.021013e-01 | 0.096 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.021013e-01 | 0.096 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.021921e-01 | 0.096 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.028879e-01 | 0.095 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.061756e-01 | 0.094 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.061756e-01 | 0.094 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.061756e-01 | 0.094 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.061756e-01 | 0.094 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.061756e-01 | 0.094 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.061756e-01 | 0.094 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.061756e-01 | 0.094 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.061756e-01 | 0.094 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.061756e-01 | 0.094 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.061756e-01 | 0.094 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 8.061756e-01 | 0.094 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.061756e-01 | 0.094 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.061756e-01 | 0.094 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.061756e-01 | 0.094 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.077801e-01 | 0.093 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.077801e-01 | 0.093 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.094786e-01 | 0.092 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.101672e-01 | 0.091 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.101672e-01 | 0.091 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.101672e-01 | 0.091 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.101672e-01 | 0.091 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.117630e-01 | 0.091 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.120114e-01 | 0.090 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.120114e-01 | 0.090 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.120114e-01 | 0.090 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.120114e-01 | 0.090 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.156588e-01 | 0.088 | 1 | 0 |
| Gastrulation | R-HSA-9758941 | 8.173687e-01 | 0.088 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.190275e-01 | 0.087 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.193111e-01 | 0.087 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.193314e-01 | 0.087 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.215191e-01 | 0.085 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.215191e-01 | 0.085 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.269933e-01 | 0.082 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.269933e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.269933e-01 | 0.082 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.278903e-01 | 0.082 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.278903e-01 | 0.082 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.278903e-01 | 0.082 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.278903e-01 | 0.082 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.278903e-01 | 0.082 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.302987e-01 | 0.081 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.309080e-01 | 0.080 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.309552e-01 | 0.080 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.309552e-01 | 0.080 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.309552e-01 | 0.080 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.309552e-01 | 0.080 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.309552e-01 | 0.080 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.309552e-01 | 0.080 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.309552e-01 | 0.080 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.309552e-01 | 0.080 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.309552e-01 | 0.080 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.309552e-01 | 0.080 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.309552e-01 | 0.080 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.309552e-01 | 0.080 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.309552e-01 | 0.080 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.309552e-01 | 0.080 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.309552e-01 | 0.080 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.309552e-01 | 0.080 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.357768e-01 | 0.078 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.370282e-01 | 0.077 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.378761e-01 | 0.077 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.378761e-01 | 0.077 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.378761e-01 | 0.077 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.382828e-01 | 0.077 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.382828e-01 | 0.077 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.392080e-01 | 0.076 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.392080e-01 | 0.076 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.392080e-01 | 0.076 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.392080e-01 | 0.076 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.407451e-01 | 0.075 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.426048e-01 | 0.074 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.426048e-01 | 0.074 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.485796e-01 | 0.071 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.485796e-01 | 0.071 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.489698e-01 | 0.071 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.504093e-01 | 0.070 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.517952e-01 | 0.070 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.525681e-01 | 0.069 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.525681e-01 | 0.069 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.525681e-01 | 0.069 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.525681e-01 | 0.069 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.525681e-01 | 0.069 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.525681e-01 | 0.069 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.525681e-01 | 0.069 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.525681e-01 | 0.069 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.525681e-01 | 0.069 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.525681e-01 | 0.069 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.525681e-01 | 0.069 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.525681e-01 | 0.069 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.535681e-01 | 0.069 | 1 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.544044e-01 | 0.068 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.552928e-01 | 0.068 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.561547e-01 | 0.067 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.562161e-01 | 0.067 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.562161e-01 | 0.067 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.562161e-01 | 0.067 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.594436e-01 | 0.066 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.619981e-01 | 0.064 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.686117e-01 | 0.061 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.687855e-01 | 0.061 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.687855e-01 | 0.061 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.696470e-01 | 0.061 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.698943e-01 | 0.061 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.698943e-01 | 0.061 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.698943e-01 | 0.061 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.712376e-01 | 0.060 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.714188e-01 | 0.060 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.714188e-01 | 0.060 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.714188e-01 | 0.060 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.714188e-01 | 0.060 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.714188e-01 | 0.060 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.714188e-01 | 0.060 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.714188e-01 | 0.060 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.714188e-01 | 0.060 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.714188e-01 | 0.060 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.723440e-01 | 0.059 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.730209e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.773479e-01 | 0.057 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.783410e-01 | 0.056 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.788320e-01 | 0.056 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.803742e-01 | 0.055 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.803742e-01 | 0.055 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.803742e-01 | 0.055 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.831288e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.831767e-01 | 0.054 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.837815e-01 | 0.054 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.865639e-01 | 0.052 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.878602e-01 | 0.052 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.878602e-01 | 0.052 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.878602e-01 | 0.052 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.878602e-01 | 0.052 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.878602e-01 | 0.052 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.878602e-01 | 0.052 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.878602e-01 | 0.052 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.878602e-01 | 0.052 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.878602e-01 | 0.052 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.878602e-01 | 0.052 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.880255e-01 | 0.052 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.880255e-01 | 0.052 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.881807e-01 | 0.051 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.910427e-01 | 0.050 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.926176e-01 | 0.049 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.926176e-01 | 0.049 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.951071e-01 | 0.048 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.951071e-01 | 0.048 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.951071e-01 | 0.048 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.951071e-01 | 0.048 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.951071e-01 | 0.048 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.951071e-01 | 0.048 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.951071e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.965664e-01 | 0.047 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.981940e-01 | 0.047 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.990354e-01 | 0.046 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.008500e-01 | 0.045 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.008500e-01 | 0.045 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.011335e-01 | 0.045 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.013822e-01 | 0.045 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.013822e-01 | 0.045 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.013822e-01 | 0.045 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.013822e-01 | 0.045 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.013822e-01 | 0.045 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.015362e-01 | 0.045 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.015362e-01 | 0.045 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.015362e-01 | 0.045 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.015362e-01 | 0.045 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.015362e-01 | 0.045 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.015362e-01 | 0.045 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.022001e-01 | 0.045 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.022001e-01 | 0.045 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.022001e-01 | 0.045 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.022001e-01 | 0.045 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.022001e-01 | 0.045 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.022001e-01 | 0.045 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.022001e-01 | 0.045 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.022001e-01 | 0.045 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.022001e-01 | 0.045 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.022001e-01 | 0.045 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.022001e-01 | 0.045 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.022001e-01 | 0.045 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.044018e-01 | 0.044 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.048632e-01 | 0.043 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.059340e-01 | 0.043 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.059340e-01 | 0.043 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.059340e-01 | 0.043 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.068907e-01 | 0.042 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.091266e-01 | 0.041 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.098533e-01 | 0.041 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.098533e-01 | 0.041 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.098533e-01 | 0.041 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.098533e-01 | 0.041 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.105755e-01 | 0.041 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.115489e-01 | 0.040 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.117142e-01 | 0.040 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.124964e-01 | 0.040 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.147070e-01 | 0.039 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.147070e-01 | 0.039 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.147070e-01 | 0.039 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.147070e-01 | 0.039 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.147070e-01 | 0.039 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.147070e-01 | 0.039 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.147070e-01 | 0.039 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.147070e-01 | 0.039 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.147070e-01 | 0.039 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.147070e-01 | 0.039 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.157080e-01 | 0.038 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.157653e-01 | 0.038 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.170338e-01 | 0.038 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.170338e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.177516e-01 | 0.037 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.180315e-01 | 0.037 | 1 | 1 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.181079e-01 | 0.037 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.181079e-01 | 0.037 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.185309e-01 | 0.037 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.185309e-01 | 0.037 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.239941e-01 | 0.034 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.243027e-01 | 0.034 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.245214e-01 | 0.034 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.245214e-01 | 0.034 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.256151e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.256151e-01 | 0.034 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.256151e-01 | 0.034 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.256151e-01 | 0.034 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.256151e-01 | 0.034 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.256151e-01 | 0.034 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.256151e-01 | 0.034 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.256151e-01 | 0.034 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.256151e-01 | 0.034 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.256151e-01 | 0.034 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.256151e-01 | 0.034 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.256667e-01 | 0.034 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.288919e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.304246e-01 | 0.031 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.307828e-01 | 0.031 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.324598e-01 | 0.030 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.324598e-01 | 0.030 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.324598e-01 | 0.030 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.324598e-01 | 0.030 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.325804e-01 | 0.030 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.325804e-01 | 0.030 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.351288e-01 | 0.029 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.351288e-01 | 0.029 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.351288e-01 | 0.029 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.351288e-01 | 0.029 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.351288e-01 | 0.029 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.351288e-01 | 0.029 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.351288e-01 | 0.029 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.351288e-01 | 0.029 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.351288e-01 | 0.029 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.351288e-01 | 0.029 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.351288e-01 | 0.029 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.351288e-01 | 0.029 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.363591e-01 | 0.029 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.363591e-01 | 0.029 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.367332e-01 | 0.028 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.388969e-01 | 0.027 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.388969e-01 | 0.027 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.388969e-01 | 0.027 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.396029e-01 | 0.027 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.413041e-01 | 0.026 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.413041e-01 | 0.026 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.413041e-01 | 0.026 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.434261e-01 | 0.025 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.434261e-01 | 0.025 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.434261e-01 | 0.025 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.434261e-01 | 0.025 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.434261e-01 | 0.025 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.434261e-01 | 0.025 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.434261e-01 | 0.025 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.434261e-01 | 0.025 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.434261e-01 | 0.025 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.446616e-01 | 0.025 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.446616e-01 | 0.025 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.460243e-01 | 0.024 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.460243e-01 | 0.024 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.460442e-01 | 0.024 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.460855e-01 | 0.024 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.480963e-01 | 0.023 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.490168e-01 | 0.023 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.499174e-01 | 0.022 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.506626e-01 | 0.022 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.506626e-01 | 0.022 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.506626e-01 | 0.022 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.506626e-01 | 0.022 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.506626e-01 | 0.022 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.506626e-01 | 0.022 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.506626e-01 | 0.022 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.506626e-01 | 0.022 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.506626e-01 | 0.022 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.508980e-01 | 0.022 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.515043e-01 | 0.022 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.517916e-01 | 0.021 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.517916e-01 | 0.021 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.535792e-01 | 0.021 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.545127e-01 | 0.020 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.547046e-01 | 0.020 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.547046e-01 | 0.020 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.547046e-01 | 0.020 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.547046e-01 | 0.020 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.547046e-01 | 0.020 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.547046e-01 | 0.020 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.547046e-01 | 0.020 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.551012e-01 | 0.020 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.553016e-01 | 0.020 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.569670e-01 | 0.019 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.569738e-01 | 0.019 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.569738e-01 | 0.019 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.569738e-01 | 0.019 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.569738e-01 | 0.019 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.569738e-01 | 0.019 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.569738e-01 | 0.019 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.569738e-01 | 0.019 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.569738e-01 | 0.019 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.569738e-01 | 0.019 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.569738e-01 | 0.019 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.569738e-01 | 0.019 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.569738e-01 | 0.019 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.590608e-01 | 0.018 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.590608e-01 | 0.018 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.608579e-01 | 0.017 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.614828e-01 | 0.017 | 1 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.616077e-01 | 0.017 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.616077e-01 | 0.017 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.616077e-01 | 0.017 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.616077e-01 | 0.017 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.616077e-01 | 0.017 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.617212e-01 | 0.017 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.617212e-01 | 0.017 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.617212e-01 | 0.017 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.624781e-01 | 0.017 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.624781e-01 | 0.017 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.624781e-01 | 0.017 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.625446e-01 | 0.017 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.630213e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.630213e-01 | 0.016 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.635908e-01 | 0.016 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.645615e-01 | 0.016 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.666190e-01 | 0.015 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.666190e-01 | 0.015 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.672784e-01 | 0.014 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.672784e-01 | 0.014 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.672784e-01 | 0.014 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.672784e-01 | 0.014 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.677434e-01 | 0.014 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.694883e-01 | 0.013 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.694883e-01 | 0.013 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.695747e-01 | 0.013 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.714649e-01 | 0.013 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.714649e-01 | 0.013 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.714649e-01 | 0.013 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.714649e-01 | 0.013 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.714649e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.714649e-01 | 0.013 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.714649e-01 | 0.013 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.716341e-01 | 0.012 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.723339e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.728192e-01 | 0.012 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.728192e-01 | 0.012 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.728458e-01 | 0.012 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.728458e-01 | 0.012 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.748573e-01 | 0.011 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.748573e-01 | 0.011 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.751159e-01 | 0.011 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.751159e-01 | 0.011 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.751159e-01 | 0.011 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.751159e-01 | 0.011 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.751159e-01 | 0.011 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.751159e-01 | 0.011 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.751159e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.753928e-01 | 0.011 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.755295e-01 | 0.011 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.755295e-01 | 0.011 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.755295e-01 | 0.011 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.757974e-01 | 0.011 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.757974e-01 | 0.011 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.757974e-01 | 0.011 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.757974e-01 | 0.011 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.765648e-01 | 0.010 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.765648e-01 | 0.010 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.779598e-01 | 0.010 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.779598e-01 | 0.010 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.780041e-01 | 0.010 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.782637e-01 | 0.010 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.783000e-01 | 0.010 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.783000e-01 | 0.010 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.783000e-01 | 0.010 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.784587e-01 | 0.009 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.784587e-01 | 0.009 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.784587e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.784827e-01 | 0.009 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.789643e-01 | 0.009 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.792692e-01 | 0.009 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.792692e-01 | 0.009 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.799894e-01 | 0.009 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.801590e-01 | 0.009 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.802539e-01 | 0.009 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.808355e-01 | 0.008 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.810768e-01 | 0.008 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.810768e-01 | 0.008 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.810768e-01 | 0.008 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.810768e-01 | 0.008 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.810768e-01 | 0.008 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.810768e-01 | 0.008 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.810768e-01 | 0.008 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.810768e-01 | 0.008 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.811908e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.813688e-01 | 0.008 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.821477e-01 | 0.008 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.821477e-01 | 0.008 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.828915e-01 | 0.007 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.829568e-01 | 0.007 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.829568e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.829568e-01 | 0.007 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.829568e-01 | 0.007 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.834985e-01 | 0.007 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.834985e-01 | 0.007 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.834985e-01 | 0.007 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.834985e-01 | 0.007 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.834985e-01 | 0.007 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.834985e-01 | 0.007 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.839449e-01 | 0.007 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.845400e-01 | 0.007 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.845815e-01 | 0.007 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.848493e-01 | 0.007 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.849100e-01 | 0.007 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.855373e-01 | 0.006 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.855681e-01 | 0.006 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.856103e-01 | 0.006 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.856103e-01 | 0.006 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.856103e-01 | 0.006 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.856103e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.856103e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.856103e-01 | 0.006 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.856103e-01 | 0.006 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.859943e-01 | 0.006 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.860659e-01 | 0.006 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.865366e-01 | 0.006 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.865366e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.870331e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.870430e-01 | 0.006 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.874520e-01 | 0.005 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.874520e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.874520e-01 | 0.005 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.874520e-01 | 0.005 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.880404e-01 | 0.005 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.880404e-01 | 0.005 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.882008e-01 | 0.005 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.883769e-01 | 0.005 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.886405e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.890581e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.890581e-01 | 0.005 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.890581e-01 | 0.005 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.890581e-01 | 0.005 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.893798e-01 | 0.005 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.893798e-01 | 0.005 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.893798e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.902289e-01 | 0.004 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.904587e-01 | 0.004 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.904587e-01 | 0.004 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.905724e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.914413e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.915861e-01 | 0.004 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.916338e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.916338e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.916800e-01 | 0.004 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.916800e-01 | 0.004 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.916800e-01 | 0.004 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.916800e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.923325e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.925781e-01 | 0.003 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.925781e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.926006e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.927156e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.927451e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.932952e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.934177e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.934177e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.936739e-01 | 0.003 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.936739e-01 | 0.003 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.936739e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.936739e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.937492e-01 | 0.003 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.941641e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.941641e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.943595e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.944839e-01 | 0.002 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.945235e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.949123e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.953122e-01 | 0.002 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.956538e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.956538e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.956538e-01 | 0.002 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.958060e-01 | 0.002 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.961118e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.962748e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.962905e-01 | 0.002 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.963431e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.963431e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.963431e-01 | 0.002 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.963431e-01 | 0.002 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.963431e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.963431e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.963431e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.963431e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.963431e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.965962e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.965999e-01 | 0.001 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.966402e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.966402e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.967676e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.968114e-01 | 0.001 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.968114e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.968114e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.968114e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.968114e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.968433e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.968477e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.970730e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.971813e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.971813e-01 | 0.001 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.972214e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.972467e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.972812e-01 | 0.001 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.974276e-01 | 0.001 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.975054e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.975174e-01 | 0.001 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.975758e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.975758e-01 | 0.001 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.975758e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.975758e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.975758e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.977826e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.977928e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.978863e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.979251e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.981571e-01 | 0.001 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.981571e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.981571e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.981588e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.983931e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.983931e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.984304e-01 | 0.001 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.984322e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.985927e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.985927e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.985927e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.985990e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.986501e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.986501e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.987785e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.987785e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.988430e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.989457e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.989927e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.990022e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.990526e-01 | 0.000 | 1 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.990685e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.990685e-01 | 0.000 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.990714e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.991904e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.992519e-01 | 0.000 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.992641e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.993582e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.993598e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.993714e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994493e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.994635e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.994635e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.995167e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.995322e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.995922e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.995922e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996104e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.996445e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996563e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.996640e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997223e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997485e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997485e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997641e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.997818e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997920e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.998190e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998439e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.998501e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998575e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998922e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998990e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999025e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999025e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999099e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999099e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999144e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999333e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999403e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999479e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999479e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999532e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999546e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999566e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999632e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999633e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999655e-01 | 0.000 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.999698e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999772e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999806e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.999823e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999849e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999852e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999915e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999933e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999934e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999948e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999950e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999967e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999973e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999975e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999983e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999983e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999987e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999987e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999988e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999990e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999993e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999994e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999995e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999997e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999998e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.121325e-14 | 13.950 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.596457e-13 | 12.066 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.014522e-12 | 11.994 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.560396e-12 | 11.592 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.722600e-12 | 11.565 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.553069e-12 | 11.593 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.713474e-12 | 11.430 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.953171e-12 | 11.403 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.953171e-12 | 11.403 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.991008e-12 | 11.302 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.909784e-12 | 11.102 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.359324e-11 | 10.867 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.917799e-11 | 10.717 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.144507e-11 | 10.669 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.481737e-11 | 10.349 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.152767e-11 | 10.038 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.131483e-10 | 9.946 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.487224e-10 | 9.604 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.816364e-10 | 9.550 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.588947e-10 | 9.338 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.372440e-10 | 9.270 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.641156e-10 | 9.249 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.922714e-10 | 9.160 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.070549e-10 | 9.151 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.070549e-10 | 9.151 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.960581e-10 | 9.157 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.134380e-09 | 8.945 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.279227e-09 | 8.893 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.279227e-09 | 8.893 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.457513e-09 | 8.836 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.141191e-09 | 8.669 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.151086e-09 | 8.667 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.366930e-09 | 8.626 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.938603e-09 | 8.532 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.014786e-09 | 8.521 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.064767e-09 | 8.514 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.315924e-09 | 8.479 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.666616e-09 | 8.436 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.598795e-09 | 8.337 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.719689e-09 | 8.173 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.310121e-09 | 8.080 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.221893e-08 | 7.913 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.451441e-08 | 7.838 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.506042e-08 | 7.822 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.683914e-08 | 7.774 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.683914e-08 | 7.774 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.646222e-08 | 7.784 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.747588e-08 | 7.758 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.946710e-08 | 7.711 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.009794e-08 | 7.697 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.159865e-08 | 7.666 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.220681e-08 | 7.654 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.647779e-08 | 7.577 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.958818e-08 | 7.402 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.915849e-08 | 7.407 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.105625e-08 | 7.387 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.804858e-08 | 7.318 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.324360e-08 | 7.274 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.713769e-08 | 7.173 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.533218e-08 | 7.185 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.163213e-08 | 7.145 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.313855e-08 | 7.136 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.756985e-08 | 7.110 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.855379e-08 | 7.105 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.509480e-08 | 7.070 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.483821e-08 | 7.023 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.108090e-07 | 6.955 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.108090e-07 | 6.955 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.261424e-07 | 6.899 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.472934e-07 | 6.832 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.596891e-07 | 6.797 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.596891e-07 | 6.797 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.636621e-07 | 6.786 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.797337e-07 | 6.745 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.881072e-07 | 6.726 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.975026e-07 | 6.704 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.348038e-07 | 6.629 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.033988e-07 | 6.518 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.108113e-07 | 6.508 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.515202e-07 | 6.454 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.399105e-07 | 6.469 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.653826e-07 | 6.437 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.077935e-07 | 6.390 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.491658e-07 | 6.348 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.879508e-07 | 6.162 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.655627e-07 | 6.116 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.546795e-07 | 6.068 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.779431e-07 | 6.010 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.080138e-06 | 5.967 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.105887e-06 | 5.956 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.112850e-06 | 5.954 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.377636e-06 | 5.861 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.492859e-06 | 5.826 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.500419e-06 | 5.824 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.637440e-06 | 5.786 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.753812e-06 | 5.756 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.768462e-06 | 5.752 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.939720e-06 | 5.712 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.882231e-06 | 5.725 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.968504e-06 | 5.706 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.979833e-06 | 5.703 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.008252e-06 | 5.697 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.975986e-06 | 5.526 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.015759e-06 | 5.521 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.901694e-06 | 5.537 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.936660e-06 | 5.532 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.278028e-06 | 5.484 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.339016e-06 | 5.476 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.636851e-06 | 5.439 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.791125e-06 | 5.421 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.480370e-06 | 5.349 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.633733e-06 | 5.334 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.301406e-06 | 5.276 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.983390e-06 | 5.223 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.574699e-06 | 5.182 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.838183e-06 | 5.165 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.290353e-06 | 5.137 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.041008e-06 | 5.095 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.272540e-06 | 5.082 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.030194e-06 | 5.095 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.995806e-06 | 5.097 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.507972e-06 | 5.070 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.129221e-06 | 5.040 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.694892e-06 | 5.013 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.019291e-05 | 4.992 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.059510e-05 | 4.975 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.095104e-05 | 4.961 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.188119e-05 | 4.925 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.288290e-05 | 4.890 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.812450e-05 | 4.742 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.135576e-05 | 4.670 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.171562e-05 | 4.663 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.171562e-05 | 4.663 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.651762e-05 | 4.576 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.746668e-05 | 4.561 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.761626e-05 | 4.559 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.318897e-05 | 4.479 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.491609e-05 | 4.457 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.491609e-05 | 4.457 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.560361e-05 | 4.449 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.581642e-05 | 4.446 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.581642e-05 | 4.446 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.806579e-05 | 4.419 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.053226e-05 | 4.392 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.405229e-05 | 4.356 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.405229e-05 | 4.356 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.513557e-05 | 4.345 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.570245e-05 | 4.340 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.612068e-05 | 4.336 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.070849e-05 | 4.295 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.179257e-05 | 4.286 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.774290e-05 | 4.239 | 1 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.804413e-05 | 4.236 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.052464e-05 | 4.152 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.867282e-05 | 4.104 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.950411e-05 | 4.048 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 9.020946e-05 | 4.045 | 1 | 1 |
| Cellular response to starvation | R-HSA-9711097 | 9.138239e-05 | 4.039 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.704762e-05 | 4.013 | 1 | 1 |
| Programmed Cell Death | R-HSA-5357801 | 1.061654e-04 | 3.974 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.084761e-04 | 3.965 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.085750e-04 | 3.964 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.106787e-04 | 3.956 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.106787e-04 | 3.956 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.221766e-04 | 3.913 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.125263e-04 | 3.949 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.226431e-04 | 3.911 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.243505e-04 | 3.905 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.306494e-04 | 3.884 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.348957e-04 | 3.870 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.425681e-04 | 3.846 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.706936e-04 | 3.768 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.968951e-04 | 3.706 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.009947e-04 | 3.697 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.064244e-04 | 3.685 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.096417e-04 | 3.679 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.239362e-04 | 3.650 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.343651e-04 | 3.630 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.360240e-04 | 3.627 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.490872e-04 | 3.604 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.599137e-04 | 3.585 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.249221e-04 | 3.488 | 1 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.585508e-04 | 3.445 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.610200e-04 | 3.442 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.517968e-04 | 3.345 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.501872e-04 | 3.347 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.359774e-04 | 3.361 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.592680e-04 | 3.338 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.948625e-04 | 3.306 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.021284e-04 | 3.299 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.102898e-04 | 3.292 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.344331e-04 | 3.272 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.344331e-04 | 3.272 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.405715e-04 | 3.267 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.405715e-04 | 3.267 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.561285e-04 | 3.255 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.672611e-04 | 3.246 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.805150e-04 | 3.236 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.916729e-04 | 3.228 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.169891e-04 | 3.210 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.211498e-04 | 3.207 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.278020e-04 | 3.202 | 0 | 0 |
| Translation | R-HSA-72766 | 6.753429e-04 | 3.170 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.918379e-04 | 3.160 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.281238e-04 | 3.138 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.301492e-04 | 3.081 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.436138e-04 | 3.074 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.686303e-04 | 3.114 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.736743e-04 | 3.059 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.991767e-04 | 3.046 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.689433e-04 | 3.014 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 9.807461e-04 | 3.008 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.017440e-03 | 2.992 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.019872e-03 | 2.991 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.046460e-03 | 2.980 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.061346e-03 | 2.974 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.091628e-03 | 2.962 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.127290e-03 | 2.948 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.171322e-03 | 2.931 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.178807e-03 | 2.929 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.185387e-03 | 2.926 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.236028e-03 | 2.908 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.246944e-03 | 2.904 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.269331e-03 | 2.896 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.288960e-03 | 2.890 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.368594e-03 | 2.864 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.498977e-03 | 2.824 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.517277e-03 | 2.819 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.622128e-03 | 2.790 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.629414e-03 | 2.788 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.705780e-03 | 2.768 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.755011e-03 | 2.756 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.767391e-03 | 2.753 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.767391e-03 | 2.753 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.167727e-03 | 2.664 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.058815e-03 | 2.686 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.166154e-03 | 2.664 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.068662e-03 | 2.684 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.286000e-03 | 2.641 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.292975e-03 | 2.640 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.470930e-03 | 2.607 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.479904e-03 | 2.606 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 2.479904e-03 | 2.606 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.509583e-03 | 2.600 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.645299e-03 | 2.578 | 1 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.656913e-03 | 2.576 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.745320e-03 | 2.561 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.850736e-03 | 2.545 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.870600e-03 | 2.542 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.903442e-03 | 2.537 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.912766e-03 | 2.536 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.912766e-03 | 2.536 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.912766e-03 | 2.536 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.912766e-03 | 2.536 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.912766e-03 | 2.536 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.004472e-03 | 2.522 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.109673e-03 | 2.507 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.372287e-03 | 2.472 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.397801e-03 | 2.469 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.421584e-03 | 2.466 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.662032e-03 | 2.436 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.677293e-03 | 2.434 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.726964e-03 | 2.429 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.515235e-03 | 2.345 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.504706e-03 | 2.346 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.479054e-03 | 2.349 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.091355e-03 | 2.388 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.123467e-03 | 2.385 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.054866e-03 | 2.392 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.002205e-03 | 2.398 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.479054e-03 | 2.349 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.668099e-03 | 2.331 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.382010e-03 | 2.358 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.782712e-03 | 2.320 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.668099e-03 | 2.331 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.504706e-03 | 2.346 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.369336e-03 | 2.360 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.310754e-03 | 2.365 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.914866e-03 | 2.308 | 1 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.212712e-03 | 2.283 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.212712e-03 | 2.283 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.227649e-03 | 2.282 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.270252e-03 | 2.278 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.270252e-03 | 2.278 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.381610e-03 | 2.269 | 1 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.649445e-03 | 2.248 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.649445e-03 | 2.248 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.649445e-03 | 2.248 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.649445e-03 | 2.248 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.674363e-03 | 2.246 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.674363e-03 | 2.246 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.995513e-03 | 2.222 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.039461e-03 | 2.219 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.847304e-03 | 2.164 | 1 | 1 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.679355e-03 | 2.175 | 1 | 1 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.627741e-03 | 2.118 | 1 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.627741e-03 | 2.118 | 1 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.627741e-03 | 2.118 | 1 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.627741e-03 | 2.118 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.627741e-03 | 2.118 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.601607e-03 | 2.119 | 1 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.098248e-03 | 2.149 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.098248e-03 | 2.149 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.098248e-03 | 2.149 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.759458e-03 | 2.170 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.759458e-03 | 2.170 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.793810e-03 | 2.168 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.793810e-03 | 2.168 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.318775e-03 | 2.199 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.867429e-03 | 2.163 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.793810e-03 | 2.168 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.585675e-03 | 2.120 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.119734e-03 | 2.148 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.119734e-03 | 2.148 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.810421e-03 | 2.107 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.131297e-03 | 2.147 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.875916e-03 | 2.163 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.131297e-03 | 2.147 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.131297e-03 | 2.147 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.099920e-03 | 2.149 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.711849e-03 | 2.113 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.708041e-03 | 2.113 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.759458e-03 | 2.170 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.222481e-03 | 2.141 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.679355e-03 | 2.175 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.793810e-03 | 2.168 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.889285e-03 | 2.103 | 1 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.052669e-03 | 2.094 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.080169e-03 | 2.093 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.226099e-03 | 2.085 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.451013e-03 | 2.073 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.621720e-03 | 2.064 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.706045e-03 | 2.060 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.706045e-03 | 2.060 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.708748e-03 | 2.060 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.776265e-03 | 2.057 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.819408e-03 | 2.055 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.301143e-03 | 2.031 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.336966e-03 | 2.030 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.336966e-03 | 2.030 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.355731e-03 | 2.029 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.481586e-03 | 2.023 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.481586e-03 | 2.023 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.528237e-03 | 2.021 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.582830e-03 | 2.019 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.636881e-03 | 2.016 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.805217e-03 | 2.009 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.835924e-03 | 2.007 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.013399e-02 | 1.994 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.013399e-02 | 1.994 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.021631e-02 | 1.991 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.032161e-02 | 1.986 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.049162e-02 | 1.979 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.056258e-02 | 1.976 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.073416e-02 | 1.969 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.073416e-02 | 1.969 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.076499e-02 | 1.968 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.076499e-02 | 1.968 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.076499e-02 | 1.968 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.076499e-02 | 1.968 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.076499e-02 | 1.968 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.092266e-02 | 1.962 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.093543e-02 | 1.961 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.113959e-02 | 1.953 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.118515e-02 | 1.951 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.120168e-02 | 1.951 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.120168e-02 | 1.951 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.142920e-02 | 1.942 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.145765e-02 | 1.941 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.153866e-02 | 1.938 | 1 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.153866e-02 | 1.938 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.167987e-02 | 1.933 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.520461e-02 | 1.818 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.371230e-02 | 1.863 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.282251e-02 | 1.892 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.448427e-02 | 1.839 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.283108e-02 | 1.892 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.538567e-02 | 1.813 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.389394e-02 | 1.857 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.500461e-02 | 1.824 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.300256e-02 | 1.886 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.520461e-02 | 1.818 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.235778e-02 | 1.908 | 1 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.308861e-02 | 1.883 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.212869e-02 | 1.916 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.212869e-02 | 1.916 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.558107e-02 | 1.807 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.201937e-02 | 1.920 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.201937e-02 | 1.920 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.300256e-02 | 1.886 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.453131e-02 | 1.838 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.500461e-02 | 1.824 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.300256e-02 | 1.886 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.300200e-02 | 1.886 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.263650e-02 | 1.898 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.559168e-02 | 1.807 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.559168e-02 | 1.807 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.300200e-02 | 1.886 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.258051e-02 | 1.900 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.404161e-02 | 1.853 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.589628e-02 | 1.799 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.589628e-02 | 1.799 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.629540e-02 | 1.788 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.644175e-02 | 1.784 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.649751e-02 | 1.783 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.649751e-02 | 1.783 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.649751e-02 | 1.783 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.649751e-02 | 1.783 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.663256e-02 | 1.779 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.678144e-02 | 1.775 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.731287e-02 | 1.762 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.756511e-02 | 1.755 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.756511e-02 | 1.755 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.794625e-02 | 1.746 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.826254e-02 | 1.738 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.868148e-02 | 1.729 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.872731e-02 | 1.728 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.895288e-02 | 1.722 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.927326e-02 | 1.715 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.018526e-02 | 1.695 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.018526e-02 | 1.695 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.018526e-02 | 1.695 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.042821e-02 | 1.690 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.042821e-02 | 1.690 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.046489e-02 | 1.689 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.046489e-02 | 1.689 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.059103e-02 | 1.686 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.059103e-02 | 1.686 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.075796e-02 | 1.683 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.082884e-02 | 1.681 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.182914e-02 | 1.661 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.186908e-02 | 1.660 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.234318e-02 | 1.651 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.234318e-02 | 1.651 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.300342e-02 | 1.638 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.307982e-02 | 1.637 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.429991e-02 | 1.614 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.450517e-02 | 1.611 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.017765e-02 | 1.520 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.854685e-02 | 1.544 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.532299e-02 | 1.596 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.532299e-02 | 1.596 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.604903e-02 | 1.584 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.433985e-02 | 1.464 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.213126e-02 | 1.493 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.735043e-02 | 1.563 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.066740e-02 | 1.513 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.066740e-02 | 1.513 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.066740e-02 | 1.513 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.426152e-02 | 1.465 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.542542e-02 | 1.595 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.771972e-02 | 1.557 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.246237e-02 | 1.489 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.974838e-02 | 1.527 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.079360e-02 | 1.512 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.532299e-02 | 1.596 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.683620e-02 | 1.434 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.683620e-02 | 1.434 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.532299e-02 | 1.596 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.735043e-02 | 1.563 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.066740e-02 | 1.513 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.604903e-02 | 1.584 | 1 | 1 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.735043e-02 | 1.563 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.066740e-02 | 1.513 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.433985e-02 | 1.464 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.427912e-02 | 1.465 | 1 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.792986e-02 | 1.554 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.181196e-02 | 1.497 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.650207e-02 | 1.438 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.354879e-02 | 1.474 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.354879e-02 | 1.474 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.626300e-02 | 1.581 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.626300e-02 | 1.581 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.213126e-02 | 1.493 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.780324e-02 | 1.556 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.213126e-02 | 1.493 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.780324e-02 | 1.556 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.107136e-02 | 1.508 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.880273e-02 | 1.541 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.017765e-02 | 1.520 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.854685e-02 | 1.544 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.854685e-02 | 1.544 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.072826e-02 | 1.512 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.683620e-02 | 1.434 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.626300e-02 | 1.581 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.974838e-02 | 1.527 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.974838e-02 | 1.527 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.974838e-02 | 1.527 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.107136e-02 | 1.508 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.213126e-02 | 1.493 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.017765e-02 | 1.520 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.017765e-02 | 1.520 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.813720e-02 | 1.551 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.213126e-02 | 1.493 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.213126e-02 | 1.493 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.665102e-02 | 1.574 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.559808e-02 | 1.592 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.683620e-02 | 1.434 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.354879e-02 | 1.474 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.683620e-02 | 1.434 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.608591e-02 | 1.443 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.683620e-02 | 1.434 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.683620e-02 | 1.434 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.604903e-02 | 1.584 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.017765e-02 | 1.520 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.767616e-02 | 1.424 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.767616e-02 | 1.424 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.810112e-02 | 1.419 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.814282e-02 | 1.419 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.899426e-02 | 1.409 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.938852e-02 | 1.405 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.960037e-02 | 1.402 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.049233e-02 | 1.393 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.049233e-02 | 1.393 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.126296e-02 | 1.384 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.128991e-02 | 1.384 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.130466e-02 | 1.384 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.133201e-02 | 1.384 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.134312e-02 | 1.384 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.134312e-02 | 1.384 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.148565e-02 | 1.382 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.194572e-02 | 1.377 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.194572e-02 | 1.377 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.194572e-02 | 1.377 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.200614e-02 | 1.377 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.214150e-02 | 1.375 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.232064e-02 | 1.373 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.316804e-02 | 1.365 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.355539e-02 | 1.361 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.355539e-02 | 1.361 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.367030e-02 | 1.360 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.367030e-02 | 1.360 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.367030e-02 | 1.360 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.367030e-02 | 1.360 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.490950e-02 | 1.348 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.490950e-02 | 1.348 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.490950e-02 | 1.348 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.642580e-02 | 1.333 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.642580e-02 | 1.333 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.642580e-02 | 1.333 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.695474e-02 | 1.328 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.695474e-02 | 1.328 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.718644e-02 | 1.326 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.718644e-02 | 1.326 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.810715e-02 | 1.318 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.015203e-02 | 1.300 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.015203e-02 | 1.300 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.015203e-02 | 1.300 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.015203e-02 | 1.300 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.124792e-02 | 1.290 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.124792e-02 | 1.290 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.141345e-02 | 1.289 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.152076e-02 | 1.288 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.159924e-02 | 1.287 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.254090e-02 | 1.280 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.254090e-02 | 1.280 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.254090e-02 | 1.280 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.254090e-02 | 1.280 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.361833e-02 | 1.271 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.465804e-02 | 1.262 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.486755e-02 | 1.261 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.503131e-02 | 1.259 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.537011e-02 | 1.257 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.537011e-02 | 1.257 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.542914e-02 | 1.256 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.671458e-02 | 1.246 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.671458e-02 | 1.246 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.741604e-02 | 1.241 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.741604e-02 | 1.241 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.741604e-02 | 1.241 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.741604e-02 | 1.241 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.741604e-02 | 1.241 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.765890e-02 | 1.239 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.841607e-02 | 1.233 | 1 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.958021e-02 | 1.225 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.958021e-02 | 1.225 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.064664e-02 | 1.217 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.066002e-02 | 1.217 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.086018e-02 | 1.216 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.252572e-02 | 1.204 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.252572e-02 | 1.204 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.307409e-02 | 1.200 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.307409e-02 | 1.200 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.432683e-02 | 1.192 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.441931e-02 | 1.191 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.442044e-02 | 1.191 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.571375e-02 | 1.182 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.726072e-02 | 1.172 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.726072e-02 | 1.172 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.726072e-02 | 1.172 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.726072e-02 | 1.172 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.726072e-02 | 1.172 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.867209e-02 | 1.163 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.867209e-02 | 1.163 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.867209e-02 | 1.163 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.867209e-02 | 1.163 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.082320e-02 | 1.150 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.103021e-02 | 1.149 | 1 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.127685e-02 | 1.147 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.127685e-02 | 1.147 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.132906e-02 | 1.147 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.132906e-02 | 1.147 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.132906e-02 | 1.147 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.155402e-02 | 1.145 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.155402e-02 | 1.145 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.155402e-02 | 1.145 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.193013e-02 | 1.143 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.193013e-02 | 1.143 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.350477e-02 | 1.134 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.350477e-02 | 1.134 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.350477e-02 | 1.134 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.350477e-02 | 1.134 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.514076e-02 | 1.124 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.548191e-02 | 1.122 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.584243e-02 | 1.120 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.584243e-02 | 1.120 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.852238e-02 | 1.105 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.968833e-02 | 1.099 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.995095e-02 | 1.097 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.995095e-02 | 1.097 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.995095e-02 | 1.097 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.998262e-02 | 1.097 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.019515e-02 | 1.096 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.019515e-02 | 1.096 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.019515e-02 | 1.096 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.019515e-02 | 1.096 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.026832e-02 | 1.095 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.354505e-02 | 1.078 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.479844e-02 | 1.072 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.546261e-02 | 1.068 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.629893e-02 | 1.064 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.629893e-02 | 1.064 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.729486e-02 | 1.059 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.729486e-02 | 1.059 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.966965e-02 | 1.047 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.966965e-02 | 1.047 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.016944e-02 | 1.045 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.016944e-02 | 1.045 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.016944e-02 | 1.045 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.073743e-02 | 1.042 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 9.073743e-02 | 1.042 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 9.073743e-02 | 1.042 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 9.073743e-02 | 1.042 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 9.073743e-02 | 1.042 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 9.073743e-02 | 1.042 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.073743e-02 | 1.042 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.073743e-02 | 1.042 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.407055e-02 | 1.027 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.480075e-02 | 1.023 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.751934e-02 | 1.011 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.851779e-02 | 1.006 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.974618e-02 | 1.001 | 0 | 0 |
| Defective SFTPA2 causes IPF | R-HSA-5687868 | 9.991237e-02 | 1.000 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.991237e-02 | 1.000 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.018369e-01 | 0.992 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.030663e-01 | 0.987 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.898476e-01 | 0.722 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.898476e-01 | 0.722 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.898476e-01 | 0.722 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.898476e-01 | 0.722 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.323757e-01 | 0.878 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.323757e-01 | 0.878 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.323757e-01 | 0.878 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.323757e-01 | 0.878 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.686792e-01 | 0.773 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.686792e-01 | 0.773 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.686792e-01 | 0.773 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.686792e-01 | 0.773 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.114445e-01 | 0.953 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.114445e-01 | 0.953 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.344182e-01 | 0.872 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.344182e-01 | 0.872 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.344182e-01 | 0.872 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.344182e-01 | 0.872 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.063925e-01 | 0.685 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.063925e-01 | 0.685 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 2.063925e-01 | 0.685 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 2.063925e-01 | 0.685 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.588525e-01 | 0.799 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.588525e-01 | 0.799 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.242838e-01 | 0.906 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.845086e-01 | 0.734 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.845086e-01 | 0.734 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.845086e-01 | 0.734 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.845086e-01 | 0.734 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.427588e-01 | 0.845 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.427588e-01 | 0.845 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.427588e-01 | 0.845 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.252820e-01 | 0.902 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.387092e-01 | 0.858 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.037604e-01 | 0.691 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.037604e-01 | 0.691 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.758056e-01 | 0.755 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.177661e-01 | 0.929 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.826745e-01 | 0.738 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.129701e-01 | 0.947 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.826061e-01 | 0.738 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.216620e-01 | 0.915 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.458233e-01 | 0.836 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.385995e-01 | 0.858 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.000466e-01 | 0.699 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.276102e-01 | 0.894 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.200198e-01 | 0.921 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.216620e-01 | 0.915 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 1.424556e-01 | 0.846 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.500459e-01 | 0.824 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.037604e-01 | 0.691 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.069592e-01 | 0.971 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.920375e-01 | 0.717 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.098214e-01 | 0.959 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.619330e-01 | 0.791 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.934945e-01 | 0.713 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.622353e-01 | 0.790 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.298285e-01 | 0.887 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.125243e-01 | 0.949 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.252820e-01 | 0.902 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.490751e-01 | 0.827 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.344182e-01 | 0.872 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.063925e-01 | 0.685 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.063925e-01 | 0.685 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.334714e-01 | 0.875 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.039558e-01 | 0.983 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.719758e-01 | 0.765 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.242838e-01 | 0.906 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.063925e-01 | 0.685 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.069122e-01 | 0.971 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.000466e-01 | 0.699 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.650402e-01 | 0.782 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.427588e-01 | 0.845 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.424556e-01 | 0.846 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.589538e-01 | 0.799 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.572133e-01 | 0.804 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.534631e-01 | 0.814 | 1 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.435899e-01 | 0.843 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.850687e-01 | 0.733 | 1 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.898476e-01 | 0.722 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.323757e-01 | 0.878 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.344182e-01 | 0.872 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.063925e-01 | 0.685 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.458233e-01 | 0.836 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.000466e-01 | 0.699 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.742424e-01 | 0.759 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.252820e-01 | 0.902 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.216620e-01 | 0.915 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.328276e-01 | 0.877 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.417025e-01 | 0.849 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.625047e-01 | 0.789 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.000466e-01 | 0.699 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.122056e-01 | 0.950 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.355029e-01 | 0.868 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.344182e-01 | 0.872 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.000466e-01 | 0.699 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.984299e-01 | 0.702 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.001733e-01 | 0.699 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.355029e-01 | 0.868 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.427588e-01 | 0.845 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.215525e-01 | 0.915 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.634344e-01 | 0.787 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.015875e-01 | 0.696 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.287110e-01 | 0.890 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.994675e-01 | 0.700 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.063925e-01 | 0.685 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.748613e-01 | 0.757 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.145336e-01 | 0.941 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.018622e-01 | 0.695 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.274844e-01 | 0.895 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.216620e-01 | 0.915 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.836194e-01 | 0.736 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.266553e-01 | 0.897 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.424556e-01 | 0.846 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.344182e-01 | 0.872 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.385995e-01 | 0.858 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.720627e-01 | 0.764 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.845086e-01 | 0.734 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.686792e-01 | 0.773 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.405337e-01 | 0.852 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.587718e-01 | 0.799 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.622353e-01 | 0.790 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.434106e-01 | 0.843 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.037604e-01 | 0.691 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.075846e-01 | 0.683 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.111525e-01 | 0.675 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.111525e-01 | 0.675 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.111525e-01 | 0.675 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.111525e-01 | 0.675 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.117733e-01 | 0.674 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.134970e-01 | 0.671 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.145763e-01 | 0.668 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.146654e-01 | 0.668 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.179446e-01 | 0.662 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.255860e-01 | 0.647 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.255860e-01 | 0.647 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.255860e-01 | 0.647 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.255860e-01 | 0.647 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.255860e-01 | 0.647 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.255860e-01 | 0.647 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.272812e-01 | 0.643 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.272812e-01 | 0.643 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.291989e-01 | 0.640 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.299168e-01 | 0.638 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.299168e-01 | 0.638 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.299168e-01 | 0.638 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.305750e-01 | 0.637 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.305750e-01 | 0.637 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.305750e-01 | 0.637 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.310825e-01 | 0.636 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.313360e-01 | 0.636 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.369591e-01 | 0.625 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.373396e-01 | 0.625 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.385595e-01 | 0.622 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.385595e-01 | 0.622 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.385595e-01 | 0.622 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.391075e-01 | 0.621 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.413742e-01 | 0.617 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.433250e-01 | 0.614 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.448720e-01 | 0.611 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.448720e-01 | 0.611 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.448720e-01 | 0.611 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.448720e-01 | 0.611 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.448720e-01 | 0.611 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.448720e-01 | 0.611 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.448720e-01 | 0.611 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.458913e-01 | 0.609 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.479709e-01 | 0.606 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 2.479709e-01 | 0.606 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.479709e-01 | 0.606 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.483957e-01 | 0.605 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.498313e-01 | 0.602 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.498313e-01 | 0.602 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.566482e-01 | 0.591 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.610321e-01 | 0.583 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.637649e-01 | 0.579 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.657976e-01 | 0.575 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.657976e-01 | 0.575 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.657976e-01 | 0.575 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.665172e-01 | 0.574 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.665172e-01 | 0.574 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.665172e-01 | 0.574 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.665172e-01 | 0.574 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.665172e-01 | 0.574 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.694739e-01 | 0.569 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.694739e-01 | 0.569 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.694739e-01 | 0.569 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.708013e-01 | 0.567 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.708013e-01 | 0.567 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.708013e-01 | 0.567 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.708013e-01 | 0.567 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.708013e-01 | 0.567 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.708013e-01 | 0.567 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.708013e-01 | 0.567 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.708013e-01 | 0.567 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.708013e-01 | 0.567 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.708013e-01 | 0.567 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.708013e-01 | 0.567 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.708013e-01 | 0.567 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.708048e-01 | 0.567 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.708048e-01 | 0.567 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.708048e-01 | 0.567 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.708048e-01 | 0.567 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.708048e-01 | 0.567 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.708048e-01 | 0.567 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.708048e-01 | 0.567 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.708048e-01 | 0.567 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.708048e-01 | 0.567 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.792457e-01 | 0.554 | 1 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.834943e-01 | 0.547 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.834943e-01 | 0.547 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.835885e-01 | 0.547 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.873102e-01 | 0.542 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.894344e-01 | 0.538 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.909174e-01 | 0.536 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.917854e-01 | 0.535 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.932443e-01 | 0.533 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.932443e-01 | 0.533 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.935088e-01 | 0.532 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.939803e-01 | 0.532 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.939803e-01 | 0.532 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.939803e-01 | 0.532 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.939803e-01 | 0.532 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.939803e-01 | 0.532 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.939803e-01 | 0.532 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.948271e-01 | 0.530 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.948271e-01 | 0.530 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.948271e-01 | 0.530 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.003074e-01 | 0.522 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.028511e-01 | 0.519 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.055626e-01 | 0.515 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.055626e-01 | 0.515 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.096458e-01 | 0.509 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.096458e-01 | 0.509 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.096458e-01 | 0.509 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.096458e-01 | 0.509 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.096741e-01 | 0.509 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.113005e-01 | 0.507 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.125805e-01 | 0.505 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.155454e-01 | 0.501 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.173940e-01 | 0.498 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.173940e-01 | 0.498 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.221107e-01 | 0.492 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.221107e-01 | 0.492 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.221107e-01 | 0.492 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.221107e-01 | 0.492 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.221107e-01 | 0.492 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.221107e-01 | 0.492 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.233067e-01 | 0.490 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.300423e-01 | 0.481 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.365780e-01 | 0.473 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.378830e-01 | 0.471 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.409474e-01 | 0.467 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.436702e-01 | 0.464 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.436702e-01 | 0.464 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.436702e-01 | 0.464 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 3.436702e-01 | 0.464 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.436702e-01 | 0.464 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.436702e-01 | 0.464 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.436702e-01 | 0.464 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.464348e-01 | 0.460 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.517896e-01 | 0.454 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.517896e-01 | 0.454 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.517896e-01 | 0.454 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.517896e-01 | 0.454 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.517896e-01 | 0.454 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.562913e-01 | 0.448 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.562913e-01 | 0.448 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.600912e-01 | 0.444 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.600912e-01 | 0.444 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.600912e-01 | 0.444 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.600912e-01 | 0.444 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.600912e-01 | 0.444 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.600912e-01 | 0.444 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.600912e-01 | 0.444 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.600912e-01 | 0.444 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.600912e-01 | 0.444 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.600912e-01 | 0.444 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.600912e-01 | 0.444 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.600912e-01 | 0.444 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.620317e-01 | 0.441 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.633329e-01 | 0.440 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.638339e-01 | 0.439 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.640160e-01 | 0.439 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.645473e-01 | 0.438 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.711387e-01 | 0.430 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.711387e-01 | 0.430 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.711387e-01 | 0.430 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.747645e-01 | 0.426 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.747645e-01 | 0.426 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.766663e-01 | 0.424 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.767357e-01 | 0.424 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.778389e-01 | 0.423 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.801258e-01 | 0.420 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.801258e-01 | 0.420 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.881063e-01 | 0.411 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.881063e-01 | 0.411 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.881063e-01 | 0.411 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.881063e-01 | 0.411 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.917185e-01 | 0.407 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.917185e-01 | 0.407 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.936671e-01 | 0.405 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.972537e-01 | 0.401 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.972537e-01 | 0.401 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.972537e-01 | 0.401 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.037157e-01 | 0.394 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.074176e-01 | 0.390 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.080181e-01 | 0.389 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.081820e-01 | 0.389 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.081820e-01 | 0.389 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.081820e-01 | 0.389 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.081820e-01 | 0.389 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.092611e-01 | 0.388 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.092611e-01 | 0.388 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.092611e-01 | 0.388 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.092611e-01 | 0.388 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.092611e-01 | 0.388 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.092611e-01 | 0.388 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.092611e-01 | 0.388 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.092611e-01 | 0.388 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.092611e-01 | 0.388 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.115435e-01 | 0.386 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.115435e-01 | 0.386 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.115435e-01 | 0.386 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.115435e-01 | 0.386 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.115435e-01 | 0.386 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.122444e-01 | 0.385 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.152399e-01 | 0.382 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.277981e-01 | 0.369 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.326638e-01 | 0.364 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.326638e-01 | 0.364 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.333826e-01 | 0.363 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.333826e-01 | 0.363 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.333826e-01 | 0.363 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.333826e-01 | 0.363 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.333826e-01 | 0.363 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.333826e-01 | 0.363 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.333826e-01 | 0.363 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.333826e-01 | 0.363 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.347841e-01 | 0.362 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.347841e-01 | 0.362 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.347841e-01 | 0.362 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.358406e-01 | 0.361 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.358406e-01 | 0.361 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.358406e-01 | 0.361 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.358406e-01 | 0.361 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.372770e-01 | 0.359 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.404842e-01 | 0.356 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.444797e-01 | 0.352 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.484764e-01 | 0.348 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.485611e-01 | 0.348 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.529277e-01 | 0.344 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.549655e-01 | 0.342 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.560940e-01 | 0.341 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.577601e-01 | 0.339 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.577601e-01 | 0.339 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.577601e-01 | 0.339 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.577601e-01 | 0.339 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.577601e-01 | 0.339 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.577601e-01 | 0.339 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.628103e-01 | 0.335 | 1 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.629994e-01 | 0.334 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.629994e-01 | 0.334 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.666678e-01 | 0.331 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.666678e-01 | 0.331 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.666678e-01 | 0.331 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.666678e-01 | 0.331 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.683006e-01 | 0.329 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.683006e-01 | 0.329 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.683006e-01 | 0.329 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.683006e-01 | 0.329 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.683006e-01 | 0.329 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.683006e-01 | 0.329 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.683006e-01 | 0.329 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.683006e-01 | 0.329 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.683006e-01 | 0.329 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.683006e-01 | 0.329 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.683006e-01 | 0.329 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.683006e-01 | 0.329 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.683006e-01 | 0.329 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.683006e-01 | 0.329 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.683006e-01 | 0.329 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.683135e-01 | 0.329 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.683135e-01 | 0.329 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.683135e-01 | 0.329 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.683135e-01 | 0.329 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.683135e-01 | 0.329 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.729905e-01 | 0.325 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.729905e-01 | 0.325 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.804098e-01 | 0.318 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.804098e-01 | 0.318 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.804098e-01 | 0.318 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.804098e-01 | 0.318 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.846950e-01 | 0.315 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.870487e-01 | 0.312 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.885887e-01 | 0.311 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.895708e-01 | 0.310 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.895708e-01 | 0.310 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.895708e-01 | 0.310 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.904250e-01 | 0.309 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.950957e-01 | 0.305 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.961005e-01 | 0.304 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.019249e-01 | 0.299 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.019249e-01 | 0.299 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.019249e-01 | 0.299 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.019249e-01 | 0.299 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 5.019249e-01 | 0.299 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.019249e-01 | 0.299 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.025270e-01 | 0.299 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.025270e-01 | 0.299 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.026781e-01 | 0.299 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.123478e-01 | 0.290 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.154808e-01 | 0.288 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.161586e-01 | 0.287 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.201351e-01 | 0.284 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.214427e-01 | 0.283 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.214427e-01 | 0.283 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.214427e-01 | 0.283 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.214427e-01 | 0.283 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.214427e-01 | 0.283 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.214427e-01 | 0.283 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.214427e-01 | 0.283 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.214427e-01 | 0.283 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.214427e-01 | 0.283 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.214427e-01 | 0.283 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.214427e-01 | 0.283 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.214427e-01 | 0.283 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.214427e-01 | 0.283 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.214427e-01 | 0.283 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.245162e-01 | 0.280 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.245162e-01 | 0.280 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.245162e-01 | 0.280 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.245162e-01 | 0.280 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.267340e-01 | 0.278 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.315689e-01 | 0.274 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.341318e-01 | 0.272 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.341318e-01 | 0.272 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.341318e-01 | 0.272 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.341318e-01 | 0.272 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.341318e-01 | 0.272 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.341318e-01 | 0.272 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.374926e-01 | 0.270 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.406679e-01 | 0.267 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.420930e-01 | 0.266 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.458813e-01 | 0.263 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.467179e-01 | 0.262 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.473347e-01 | 0.262 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.504417e-01 | 0.259 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.504417e-01 | 0.259 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.504417e-01 | 0.259 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.581916e-01 | 0.253 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.583935e-01 | 0.253 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.583935e-01 | 0.253 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.648792e-01 | 0.248 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.648792e-01 | 0.248 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.648792e-01 | 0.248 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.648792e-01 | 0.248 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.648792e-01 | 0.248 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.648792e-01 | 0.248 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.648792e-01 | 0.248 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.650825e-01 | 0.248 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.650825e-01 | 0.248 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.667364e-01 | 0.247 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.689383e-01 | 0.245 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.689383e-01 | 0.245 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.692763e-01 | 0.245 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.692763e-01 | 0.245 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.692763e-01 | 0.245 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.692763e-01 | 0.245 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.692763e-01 | 0.245 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.692763e-01 | 0.245 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.692763e-01 | 0.245 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.692763e-01 | 0.245 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.692763e-01 | 0.245 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.692763e-01 | 0.245 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.692763e-01 | 0.245 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.692763e-01 | 0.245 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.692763e-01 | 0.245 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.715736e-01 | 0.243 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.731669e-01 | 0.242 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.731669e-01 | 0.242 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.778103e-01 | 0.238 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.870502e-01 | 0.231 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.870502e-01 | 0.231 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.876114e-01 | 0.231 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.886855e-01 | 0.230 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.886855e-01 | 0.230 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.941371e-01 | 0.226 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.941371e-01 | 0.226 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.941371e-01 | 0.226 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.941371e-01 | 0.226 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.941371e-01 | 0.226 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.941371e-01 | 0.226 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.941371e-01 | 0.226 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.958203e-01 | 0.225 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.047067e-01 | 0.218 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.047067e-01 | 0.218 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.054885e-01 | 0.218 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.067966e-01 | 0.217 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.067966e-01 | 0.217 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.067966e-01 | 0.217 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.123312e-01 | 0.213 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.123312e-01 | 0.213 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.123312e-01 | 0.213 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.123312e-01 | 0.213 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.123312e-01 | 0.213 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.123312e-01 | 0.213 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.123312e-01 | 0.213 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.123312e-01 | 0.213 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.218960e-01 | 0.206 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.218960e-01 | 0.206 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.218960e-01 | 0.206 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.259544e-01 | 0.203 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.259544e-01 | 0.203 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.259544e-01 | 0.203 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.333482e-01 | 0.198 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.333482e-01 | 0.198 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.333482e-01 | 0.198 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.333482e-01 | 0.198 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.333482e-01 | 0.198 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.341887e-01 | 0.198 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 6.387142e-01 | 0.195 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.387142e-01 | 0.195 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.481633e-01 | 0.188 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.481633e-01 | 0.188 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.481633e-01 | 0.188 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.502146e-01 | 0.187 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.510846e-01 | 0.186 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.510846e-01 | 0.186 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.510846e-01 | 0.186 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.510846e-01 | 0.186 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.510846e-01 | 0.186 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.510846e-01 | 0.186 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.510846e-01 | 0.186 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.510846e-01 | 0.186 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.510846e-01 | 0.186 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.510846e-01 | 0.186 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 6.510846e-01 | 0.186 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.510846e-01 | 0.186 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.510846e-01 | 0.186 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.510846e-01 | 0.186 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.510846e-01 | 0.186 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.510846e-01 | 0.186 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.510846e-01 | 0.186 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.624423e-01 | 0.179 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.626625e-01 | 0.179 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.648747e-01 | 0.177 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.648747e-01 | 0.177 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.708482e-01 | 0.173 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.708482e-01 | 0.173 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.708482e-01 | 0.173 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.708482e-01 | 0.173 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.715557e-01 | 0.173 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.729597e-01 | 0.172 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.729597e-01 | 0.172 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.745205e-01 | 0.171 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.745205e-01 | 0.171 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.752176e-01 | 0.171 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.768229e-01 | 0.170 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.807638e-01 | 0.167 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.807638e-01 | 0.167 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.807638e-01 | 0.167 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.859661e-01 | 0.164 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.859661e-01 | 0.164 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.859661e-01 | 0.164 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.859661e-01 | 0.164 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.859661e-01 | 0.164 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.859661e-01 | 0.164 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.859661e-01 | 0.164 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.859661e-01 | 0.164 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.859661e-01 | 0.164 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.859661e-01 | 0.164 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.859661e-01 | 0.164 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.859661e-01 | 0.164 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.859661e-01 | 0.164 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.937865e-01 | 0.159 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.937865e-01 | 0.159 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.937865e-01 | 0.159 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.961428e-01 | 0.157 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.963167e-01 | 0.157 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.963167e-01 | 0.157 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.963167e-01 | 0.157 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.963167e-01 | 0.157 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.010385e-01 | 0.154 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.064738e-01 | 0.151 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.121779e-01 | 0.147 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.121779e-01 | 0.147 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.124776e-01 | 0.147 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.124776e-01 | 0.147 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 7.124776e-01 | 0.147 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.124776e-01 | 0.147 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.173623e-01 | 0.144 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.173623e-01 | 0.144 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.173623e-01 | 0.144 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.173623e-01 | 0.144 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.173623e-01 | 0.144 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.173623e-01 | 0.144 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.173623e-01 | 0.144 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.173623e-01 | 0.144 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.173623e-01 | 0.144 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.173623e-01 | 0.144 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.182744e-01 | 0.144 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.182744e-01 | 0.144 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.182744e-01 | 0.144 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.197103e-01 | 0.143 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.278940e-01 | 0.138 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.292522e-01 | 0.137 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.297048e-01 | 0.137 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.297048e-01 | 0.137 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.319709e-01 | 0.136 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.344433e-01 | 0.134 | 1 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.388789e-01 | 0.131 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.388789e-01 | 0.131 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.388789e-01 | 0.131 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.388789e-01 | 0.131 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.395932e-01 | 0.131 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.426164e-01 | 0.129 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.446041e-01 | 0.128 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.456213e-01 | 0.127 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.456213e-01 | 0.127 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.456213e-01 | 0.127 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.456213e-01 | 0.127 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.456213e-01 | 0.127 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.456213e-01 | 0.127 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.456213e-01 | 0.127 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.456213e-01 | 0.127 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.456213e-01 | 0.127 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.568541e-01 | 0.121 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.568541e-01 | 0.121 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.568541e-01 | 0.121 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.581813e-01 | 0.120 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.704130e-01 | 0.113 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.710564e-01 | 0.113 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.710564e-01 | 0.113 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.710564e-01 | 0.113 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.710564e-01 | 0.113 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.710564e-01 | 0.113 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.710564e-01 | 0.113 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.710564e-01 | 0.113 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.710564e-01 | 0.113 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.735333e-01 | 0.112 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.762360e-01 | 0.110 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.762360e-01 | 0.110 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.801966e-01 | 0.108 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.890798e-01 | 0.103 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.914139e-01 | 0.102 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.914947e-01 | 0.102 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.930994e-01 | 0.101 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.930994e-01 | 0.101 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.939495e-01 | 0.100 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.939495e-01 | 0.100 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.939495e-01 | 0.100 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.939495e-01 | 0.100 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.939495e-01 | 0.100 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.939495e-01 | 0.100 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.939495e-01 | 0.100 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.939495e-01 | 0.100 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.939495e-01 | 0.100 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.957399e-01 | 0.099 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.957485e-01 | 0.099 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.049680e-01 | 0.094 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.049680e-01 | 0.094 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.075333e-01 | 0.093 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.088291e-01 | 0.092 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.088291e-01 | 0.092 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.088291e-01 | 0.092 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.088291e-01 | 0.092 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.109996e-01 | 0.091 | 1 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.145547e-01 | 0.089 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.145547e-01 | 0.089 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.145547e-01 | 0.089 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.145547e-01 | 0.089 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.145547e-01 | 0.089 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.145547e-01 | 0.089 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.145547e-01 | 0.089 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.145547e-01 | 0.089 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.145547e-01 | 0.089 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.156476e-01 | 0.088 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.187657e-01 | 0.087 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.234833e-01 | 0.084 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.234833e-01 | 0.084 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.254742e-01 | 0.083 | 1 | 1 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.276416e-01 | 0.082 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.318126e-01 | 0.080 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.323035e-01 | 0.080 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.331005e-01 | 0.079 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.331005e-01 | 0.079 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.331005e-01 | 0.079 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.331005e-01 | 0.079 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.331005e-01 | 0.079 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.348423e-01 | 0.078 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.371197e-01 | 0.077 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.398048e-01 | 0.076 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.414812e-01 | 0.075 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.414812e-01 | 0.075 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.414812e-01 | 0.075 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.417266e-01 | 0.075 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.450072e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.497925e-01 | 0.071 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.497925e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.497925e-01 | 0.071 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.497925e-01 | 0.071 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.497952e-01 | 0.071 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.497952e-01 | 0.071 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.497952e-01 | 0.071 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.517236e-01 | 0.070 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.577120e-01 | 0.067 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.585956e-01 | 0.066 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.585956e-01 | 0.066 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.587310e-01 | 0.066 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.615656e-01 | 0.065 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.648160e-01 | 0.063 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.648160e-01 | 0.063 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.648160e-01 | 0.063 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.648160e-01 | 0.063 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.648160e-01 | 0.063 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.648160e-01 | 0.063 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.648160e-01 | 0.063 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.648160e-01 | 0.063 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.665563e-01 | 0.062 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.680077e-01 | 0.061 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.712053e-01 | 0.060 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.724852e-01 | 0.059 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.752842e-01 | 0.058 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.783377e-01 | 0.056 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.783377e-01 | 0.056 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.783377e-01 | 0.056 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.783377e-01 | 0.056 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.783377e-01 | 0.056 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.783377e-01 | 0.056 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.783377e-01 | 0.056 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.783377e-01 | 0.056 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.783377e-01 | 0.056 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.783377e-01 | 0.056 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.783377e-01 | 0.056 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.783377e-01 | 0.056 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.800701e-01 | 0.055 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.826062e-01 | 0.054 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.826062e-01 | 0.054 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.830523e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.883877e-01 | 0.051 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.883877e-01 | 0.051 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.883877e-01 | 0.051 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.883877e-01 | 0.051 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.905076e-01 | 0.050 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.905076e-01 | 0.050 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.905076e-01 | 0.050 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.905076e-01 | 0.050 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.905076e-01 | 0.050 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.905076e-01 | 0.050 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.905076e-01 | 0.050 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.905076e-01 | 0.050 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.905076e-01 | 0.050 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.905076e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.905076e-01 | 0.050 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.919791e-01 | 0.050 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.947133e-01 | 0.048 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.948117e-01 | 0.048 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.965896e-01 | 0.047 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.993548e-01 | 0.046 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.006524e-01 | 0.045 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.006524e-01 | 0.045 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.014608e-01 | 0.045 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.014608e-01 | 0.045 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.014608e-01 | 0.045 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.014608e-01 | 0.045 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.014608e-01 | 0.045 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.014608e-01 | 0.045 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.014608e-01 | 0.045 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.014608e-01 | 0.045 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.034797e-01 | 0.044 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.034797e-01 | 0.044 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.034891e-01 | 0.044 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.086721e-01 | 0.042 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.113189e-01 | 0.040 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.113189e-01 | 0.040 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.113189e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.113189e-01 | 0.040 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.160822e-01 | 0.038 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.167187e-01 | 0.038 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.201912e-01 | 0.036 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.201912e-01 | 0.036 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.201912e-01 | 0.036 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.201912e-01 | 0.036 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.225633e-01 | 0.035 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.229243e-01 | 0.035 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.229243e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.281764e-01 | 0.032 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.281764e-01 | 0.032 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.281764e-01 | 0.032 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.281764e-01 | 0.032 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.292379e-01 | 0.032 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.313615e-01 | 0.031 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.320115e-01 | 0.031 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.334606e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.334817e-01 | 0.030 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.350603e-01 | 0.029 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.353630e-01 | 0.029 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.353630e-01 | 0.029 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.353630e-01 | 0.029 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.353630e-01 | 0.029 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.353630e-01 | 0.029 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.353630e-01 | 0.029 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.394675e-01 | 0.027 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.404264e-01 | 0.027 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.404264e-01 | 0.027 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.404264e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.418310e-01 | 0.026 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.418310e-01 | 0.026 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.418310e-01 | 0.026 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.418310e-01 | 0.026 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.418310e-01 | 0.026 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.428659e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.428659e-01 | 0.026 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.442239e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.476520e-01 | 0.023 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.476520e-01 | 0.023 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.476520e-01 | 0.023 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.476520e-01 | 0.023 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.476520e-01 | 0.023 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.477578e-01 | 0.023 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.479956e-01 | 0.023 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.499199e-01 | 0.022 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.499199e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.499199e-01 | 0.022 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.503370e-01 | 0.022 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.505568e-01 | 0.022 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.510086e-01 | 0.022 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.528909e-01 | 0.021 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.528909e-01 | 0.021 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.528909e-01 | 0.021 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.528909e-01 | 0.021 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.528909e-01 | 0.021 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.541072e-01 | 0.020 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.541072e-01 | 0.020 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.546611e-01 | 0.020 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.546611e-01 | 0.020 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.576057e-01 | 0.019 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.576057e-01 | 0.019 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.576057e-01 | 0.019 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.576057e-01 | 0.019 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.576057e-01 | 0.019 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.579583e-01 | 0.019 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.584977e-01 | 0.018 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.607933e-01 | 0.017 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.614986e-01 | 0.017 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.618489e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.618489e-01 | 0.017 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.618489e-01 | 0.017 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.618489e-01 | 0.017 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.618489e-01 | 0.017 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 9.618489e-01 | 0.017 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.635747e-01 | 0.016 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.653271e-01 | 0.015 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.653271e-01 | 0.015 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.656677e-01 | 0.015 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.656677e-01 | 0.015 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.656677e-01 | 0.015 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.656677e-01 | 0.015 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.668691e-01 | 0.015 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.668691e-01 | 0.015 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.677394e-01 | 0.014 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.691044e-01 | 0.014 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.691044e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.691044e-01 | 0.014 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.691044e-01 | 0.014 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.691044e-01 | 0.014 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.693956e-01 | 0.013 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.707132e-01 | 0.013 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.710759e-01 | 0.013 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.717391e-01 | 0.012 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.739118e-01 | 0.011 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.749806e-01 | 0.011 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.749806e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.749806e-01 | 0.011 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.759417e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.774856e-01 | 0.010 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.774856e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.774856e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.774856e-01 | 0.010 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.777904e-01 | 0.010 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.777904e-01 | 0.010 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.793685e-01 | 0.009 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.795273e-01 | 0.009 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.797398e-01 | 0.009 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.797398e-01 | 0.009 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.797398e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.797785e-01 | 0.009 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.811158e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.811476e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.812405e-01 | 0.008 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.817685e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.834453e-01 | 0.007 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.835941e-01 | 0.007 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.835941e-01 | 0.007 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.835941e-01 | 0.007 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.839623e-01 | 0.007 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.845823e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.845823e-01 | 0.007 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.851976e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.852370e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.852370e-01 | 0.006 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.863951e-01 | 0.006 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.866466e-01 | 0.006 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.867155e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.870674e-01 | 0.006 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.877573e-01 | 0.005 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.880460e-01 | 0.005 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.880460e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.880460e-01 | 0.005 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.880460e-01 | 0.005 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.891390e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.900353e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.903208e-01 | 0.004 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.903208e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.903208e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.903208e-01 | 0.004 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.909104e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.917691e-01 | 0.004 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.919757e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.921629e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.924131e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.929480e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.934602e-01 | 0.003 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.937186e-01 | 0.003 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.941142e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.942754e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.942904e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.942904e-01 | 0.002 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.942904e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.951897e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.952478e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.958405e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.962574e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.975350e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.975350e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.975470e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.975470e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.977115e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.977570e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.979607e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.980142e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.980827e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.981434e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.981988e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.983112e-01 | 0.001 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.985265e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.986707e-01 | 0.001 | 1 | 0 |
| Keratinization | R-HSA-6805567 | 9.988376e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.988449e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.988454e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.989466e-01 | 0.000 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.990523e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.990529e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.990777e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.991473e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.992328e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992748e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.993582e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.994974e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.994974e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.996340e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996340e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996707e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997370e-01 | 0.000 | 1 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997603e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.997603e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997603e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997749e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997843e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.997957e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998430e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998474e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998688e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998700e-01 | 0.000 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.998729e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998744e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999229e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999378e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999378e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999394e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999456e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999495e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999559e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999612e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999621e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999752e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999754e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999800e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999885e-01 | 0.000 | 1 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999945e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999952e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999958e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999971e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999985e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999987e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999991e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999994e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999996e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |